Method for generating recombinant dna library using unidirectional single-stranded dna fragments

ABSTRACT

The present invention relates to a method for producing a recombinant polynucleotides comprising the steps of generating a pool of unidirectional single-stranded polynucleotide fragments from two or more homologous double-stranded polynucleotides, conducting a polymerization process comprising multi-cyclic extension reactions using the unidirectional single-stranded polynucleotide fragments as templates and specific oligonucleotides as primers to obtain recombinant polynucleotides, and conducting a polymerase chain reaction using at least one primer to amplify the recombinant polynucleotides; and a method for constructing a recombinant DNA library comprising the steps of inserting the recombinant polynucleotide prepared by the above method into a vector and transforming an expression cell with said vector containing the recombinant polynucleotide to obtain a plurality of mutant clones. The method of the present invention can be used for in vitro recombination of homologous polynucleotides and the directed molecular evolution.

FIELD OF THE INVENTION

[0001] The present invention relates to a method for the production of a pool of recombinant DNA encoding mutant proteins and a recombinant DNA library comprising same, which allows the directed evolution of proteins by in vitro recombination.

BACKGROUND OF THE INVENTION

[0002] Genetic information is eventually decoded into a protein which performs most of the vital functions in living organisms. As one of important biological macromolecules, protein not only serves as a component of cells but also participates in all the biochemical reactions with a high specificity.

[0003] The function of protein comprised of 20 kinds of amino acids is determined by the structure which is divided into four levels; primary, secondary, tertiary and quaternary structures. Since the primary structure of protein, i.e., amino acid sequence, especially contains the information regarding the shape and the function thereof, the whole structure or function of the protein can be changed even by a mutation in one amino acid residue (Shao, Z. and Arnold F. H., Curr. Opin. Struct. Biol. 6:513-518, 1996).

[0004] The diversity of organism reflects the diversity of genetic information encoded in DNA or RNA. In nature, the genetic information is changed slowly and continuously by a natural evolution process comprising mutation, sexual reproduction and natural selection. For example, during meiosis in sexual reproduction, homologous chromosomes derived from two individuals might exchange or reassemble their genetic materials through homologous recombination. Such reassembly of the DNA provides more chances for living organisms to expedite an evolution. However, it takes long time for this type of evolution to occur in natural environment, partly due to its strong dependency on fortuity. Therefore, there have been many efforts to obtain, in a short period of time, a gene evolved for the desired purpose and a mutant protein by in vitro mutagenesis in combination with an appropriate screening method (Eigen, M., Naturwissenschaften 58:465-523, 1971; Bradt, R. M., Nature 317:804-806, 1985; Pal, K. F., Bio. Cybern. 69:539-546, 1993).

[0005] Current method in widespread use for creating mutant proteins is site-directed mutagenesis (Sambrook, J. et al., Molecular Cloning 2nd, Cold Spring Harbor Lab Press, 1989). This method replaces nucleotides of desired site with a synthetically mutagenized oligonucleotide. However, there are limitations of the method in that it requires exact information on the amino acid sequence and the function of the site to be mutagenized in-proteins. As another method for creating mutant proteins in a recombinant DNA library format, error-prone polymerase chain reaction (error-prone PCR) is used widely (Leung, D. W. et al., Technique 1:11-15, 1989; Caldwell, R. C. et al., PCR Methods and Applications 2:28-33, 1992). Error-prone PCR can be used for constructing a mutant DNA library of a gene by controlling the polymerization conditions to decrease the fidelity of polymerase. However, the error-prone PCR suffers from a low processibility of the polymerase, which limits the practical applications of the method for average-sized gene. Another limitation of error-prone PCR is that the frequency of co-occurrence of a plurality of mutations within a short-length region of DNA is too low for multiple mutations to be introduced.

[0006] To overcome said shortcomings of these methods, various methods for constructing a mutant DNA library from the mixture of homologous polynucleotides have been developed. Those are DNA shuffling method of Maxygen (U.S. Pat. Nos. 5,605,793; 6,117,679; 6,132,970), Gene Reassembly method of Diversa (U.S. Pat. No. 5,965,408) and recombination method developed by Frances H. Arnold (U.S. Pat. No. 6,153,410).

[0007] The DNA shuffling method of Maxygen, Inc. (U.S. Pat. Nos. 5,605,793; 6,117,679 and 6,132,970; Stemmer, W. P. C., Nature, 370: 389-391, 1994; Stemmer, W. P. C., Proc. Natl. Acad. Sci. USA, 91: 10747-10751, 1994) comprises the steps of fragmenting at least one kind of double-stranded DNAs to be shuffled and conducting polymerase chain reactions (PCR) with the combined fragments, wherein the homologous fragments from different parent DNAs are annealed with each other to form partially overlapping DNA segments and DNA synthesis occurs by employing the respective DNA fragments as a template concurrently as a primer for each other to produce a random recombinant DNA library. However, this method requires a relatively large amount of DNA for preparing DNA fragments and DNase I used in the fragmentation process has to be removed from the resulting DNA fragments in an enough purity not to disturb subsequent polymerization process. Further, the application of the method is limited by the property of the DNase I. For example, DNase I widely used for the purpose is liable to cleave a 3′-phosphodiester bond having a pyrimidine base rather than a purine base at its terminus, which is a serious obstacle to get a completely randomized pool of DNA fragments (Shao, Z. et al, Nucleic Acids Res. 26:681-683, 1998).

[0008] Gene Reassembly method of Diversa Corporation (U.S. Pat. No. 5,965,408) comprises the steps of synthesizing DNA fragments by polymerization process employing at least one kind of double-stranded DNAs to be shuffled as templates and conducting polymerase chain reactions (PCR) with the combined fragments to produce a random recombinant DNA library. It employs partially synthesized fragments produced by UV treatment or adduct formation on the template DNA, thus preventing a complete polymerization on the template DNA. Despite of the randomness of the constructed DNA library, there are still problems for the method of Diversa Corporation in view of mutagenic potential of used reagents and tediousness to optimize the reaction conditions for the treatment of polymerization terminating reagent to obtain the desired size of fragments. In addition, when pyrimidine bases exist contiguously on the DNA strand, UV treatment induces pyrimidine dimers such as a thymidine dimer, which makes the template DNA distorted and prevent the progress of polymerase along with the strand. As a result, polymerizations are likely to end up at the site of pyrimidine dimer, thus DNA fragments obtained having insufficient randomness.

[0009] DNA shuffling and Gene Reassembly methods are characterized in that the formation of partially overlapping DNA segments is a prerequisite step and each DNA fragment derived from starting DNAs to be shuffled serves as not only a template but a primer.

[0010] Another method proposed by Arnold, staggered extension process (StEP)(U.S. Pat. No. 6,153,410; Zhao, H. et al., Nat. Biotechnol. 16:258-261, 1998; Encell, L. P. et al., Nature Biotech. 16:234-235, 1998) involves priming template double-stranded polynucleotides with random or specific primers, conducting PCR while controlling the reaction conditions to produce, in each cycle of reactions, short DNA fragments of staggered extension from the templates, and conducting repeated PCR to accomplish the recombination between genes by template switching. In case of polymerase reaction, there exist specific sequence-specific pause sites in each of target DNAs. In this line, StEP method has a problem in that the recombinant DNA library is biased from randomness since the extension rate of DNA fragments extended from the primers differs from each other even if the primers are annealed to the same region of different template DNAs (Encell, L. P. and Loeb, L. A., Nature Biotech., 16: 234-235 (1998)). In StEP method, PCR conditions have to be strictly controlled in order to get short DNA fragments from staggered extension of primers by shortening the polymerization time and lowering the reaction temperature. Failure to maintain the desirable range of temperature (e.g., too low temperature) during PCR process in StEP method may lead to non-specific annealing and further formation of undesirable recombinants.

[0011] A method for constructing a recombinant DNA library whereby said drawbacks of the conventional methods are overcome would be powerful for the production of mutant proteins having improved properties. The present invention described herein is directed to a method of in vitro recombination of heterologous DNA strands, which comprises preparing unidirectional single-stranded DNA fragments, mixing the DNA fragments with specific primers, followed by polymerization and further repeating the above steps to produce a recombinant DNA library. Further advantages of the present invention will become apparent from the following description of the invention with reference to the attached drawings.

SUMMARY OF THE INVENTION

[0012] Accordingly, it is an object of the present invention to provide a method for producing various recombinant polynucleotides through the random recombination between two or more homologous double-stranded polynucleotides.

[0013] Another object of the present invention is to provide a method for constructing a recombinant DNA library, which comprises the steps of inserting said recombinant polynucleotides into a vector and transforming an expression cell with the resulting vector to obtain a plurality of mutant clones.

[0014] A further object of the present invention is to provide a method for identifying an improved mutant gene by screening recombinant polynucleotides having a desired functional properties from said recombinant DNA library.

[0015] In accordance with one aspect of the present invention, there is provided a method for constructing a recombinant DNA library comprising the steps of:

[0016] (a) generating a pool of unidirectional single-stranded polynucleotide fragments randomized in length from two or more starting polynucleotides to be reassembled which have regions of similarity with each other;

[0017] (b) conducting a polymerization process comprising multi-cyclic extension reactions wherein the unidirectional single-stranded polynucleotide fragments prepared by step (a) serve only as templates and specific oligonucleotides are added to the reaction mixture as primers,

[0018] the primers being extended sequentially with directionality by means of template switching to produce at least one recombinant polynucleotide, and the resulting recombinant polynucleotide being different from the starting polynucleotides in nucleotide sequence; and

[0019] (c) conducting a polymerase chain reaction using at least one specific primer to amplify the recombinant polynucleotides prepared by step (b).

[0020] In accordance with another aspect of the present invention, there is provided a method for constructing a recombinant DNA library, comprising the steps of inserting the recombinant polynucleotide prepared by the above method into a vector; and transforming an expression cell with said vector containing the recombinant polynucleotide to obtain a plurality of mutant clones.

[0021] In accordance with a further aspect of the present invention, there is provided a method for evolving a polynucleotide toward a desired property which comprises screening recombinant polynucleotides having a desired functional properties from the recombinant DNA library constructed by the above method.

BRIEF DESCRIPTION OF THE DRAWINGS

[0022] The above and other objects and features of the present invention will become apparent from the following description of the invention, when taken in conjunction with the accompanying drawings, in which:

[0023]FIG. 1 shows the schematic diagram illustrating the inventive method for constructing a recombinant DNA library employing unidirectional single-stranded polynucleotide fragments as templates for the polymerase chain reaction.

[0024]FIG. 2 compares the nucleotide sequences of the chitinase genes of Serratia liquefaciens (l-chi)(SEQ ID NO: 1) and Serratia marcescens (m-chi) (SEQ ID NO: 2). The corresponding bases of the two genes different from each other are marked by small letters.

[0025]FIG. 3 displays the result of 1% agarose gel electrophoresis, wherein lane 1 of (a) is a standard DNA size marker (23, 9.4, 6.6, 4.4, 2.3, 2.0 and 0.56 kb from the top), lane 2 of (a), in vitro transcription product of chitinase gene of Serratia marcescens, lane 3 of (a), in vitro transcription product of chitinase gene of Serratia liquefaciens; lane 1 of (b) is a standard DNA size marker (23, 9.4, 6.6, 4.4, 2.3, 2.0 and 0.56 kb from the top), and lane 2 of (b), single-stranded DNA fragments produced by reverse transcription; and lane 1 of (c) is a standard DNA size marker (23, 9.4, 6.6, 4.4, 2.3, 2.0 and 0.56 kb from the top), and lane 2 of (c). PCR products produced by employing unidirectional single-stranded DNA fragments as templates.

[0026]FIG. 4 represents the result of 1% agarose gel electrophoresis of the digestion products obtained by extracting the plasmid DNAs from 14 clones randomly selected from the recombinant DNA library prepared by the inventive method and digesting the plasmid DNAs with restriction enzymes NotI, PstI and HincII. Lane 1 is a standard DNA size marker and lanes 2 to 15, digestion products of the plasmid DNAs from the randomly selected 14 clones.

[0027]FIG. 5 compares the nucleotide sequences of the 10 recombinant DNAs. (SEQ ID NOs: 3 to 12), which are randomly selected from the recombinant DNA library produced by the method of the present invention, with those of two wild-type genes, i.e., l-chi gene (SEQ ID NO: 1) and m-chi gene (SEQ ID NO: 2).

[0028]FIG. 6 is a schematic diagram showing the constitutions of the mutant recombinant DNAs of FIG. 5 in comparison with the two wild-type genes.

[0029]FIG. 7 shows the difference in the sizes of the clear zones made by the colonies expressing the recombinant chitinase genes on LB-agar plates containing 100 μg/ml ampicillin and 0.5% swollen chitin, depending on the chitin decomposition capabilities of the colonies.

[0030]FIG. 8 compares the nucleotide sequence of R-24 chininase gene (SEQ ID NOs: 13) with those of two wild-type genes, i.e., l-chi gene (SEQ ID NO: 1) and m-chi gene (SEQ ID NO: 2).

[0031]FIG. 9 is a schematic diagram showing the constitution of R-24 chininase gene in comparison with the two wild-type genes.

[0032]FIG. 10 compares the nucleotide sequences of M-13 mutant (SEQ ID NO: 15) and M-20 mutant (SEQ ID NO: 16) with that of wild-type chitosanase gene (SEQ ID NO: 14).

[0033]FIG. 11 depicts the differences in heat-stabilities of wild-type chitosanase derived from Bacillus sp. KCTC 0377BP, mutant M-13 and mutant M-20.

DETAILED DESCRIPTION OF THE INVENTION

[0034] The present inventors have endeavored to develop a new method for solving the problems of the prior art, and have accomplished the present invention by establishing a new method for producing a recombinant DNA library wherein a pool of various recombinant DNAs can be obtained more easily owing to the increased randomness introduced by a new principle different from those of the prior art.

[0035] The above-described DNA shuffling method of Maxygen, Inc. (U.S. Pat. Nos. 5,605,793; 6,117,679; and 6,132,970) and Gene Reassembly method of Diversa Corporation (U.S. Pat. No. 5,965,408) are commonly characterized in that the double-stranded DNA fragments obtained from more than two polynucleotides to be reassembled are converted to single stands and then annealed with each other to form partially overlapping DNA segments, and, accordingly, they are used as primers as well as templates for nucleotide extension in the polymerase chain reaction (U.S. Pat. Nos. 4,683,202 and 4,683,195) and elongated by repeating identical multi-cyclic polymerization reactions. In contrast, the method of the present invention is basically different from the prior art in that the unidirectional single-stranded polynucleotide fragments derived from two or more polynucleotides to be reassembled are used and, accordingly, no partially overlapping DNA segments are formed within the pool of single-stranded polynucleotide fragments and the unidirectional polynucleotide fragments serve only as templates; that just the oligonucleotides added as primers are elongated gradually with a directionality using the unidirectional single-stranded polynucleotide fragments as templates; and that recombination is introduced by template switching during this PCR process. Further, unlike the Arnold's StEP method (U.S. Pat. No. 6,153,410) which employs the stringent conditions controlling temperature and reaction time to produce partially elongated DNA fragment from the double-stranded target DNA used as a template, the method of the present invention uses DNA fragments as templates and, therefore, DNA fragments elongated as long as the template DNA fragments can be obtained by employing a conventional condition of polymerization reaction. Further, it is possible to increase the randomness of recombination significantly since the inventive method is not influenced by the delayed elongation rate of polymerase at the sequence-specific pause sites.

[0036] The method of the present invention for producing mutant recombinant polynucleotides provides a method for producing a group of various recombinant genes by exchanging parts of two or more homologous genes with each other, and comprises the steps of:

[0037] (a) generating a pool of unidirectional single-stranded polynucleotide fragments randomized in length from two or more starting polynucleotides to be reassembled which have regions of similarity with each other;

[0038] (b) conducting a polymerization process comprising multi-cyclic extension reactions wherein the unidirectional single-stranded polynucleotide fragments prepared by step (a) serve only as templates and specific oligonucleotides are added to the reaction mixture as primers, the primers being extended sequentially with directionality by means of template switching to produce at least one recombinant polynucleotide, and the resulting recombinant polynucleotide being different from the starting polynucleotides in nucleotide sequence; and

[0039] (c) conducting a polymerase chain reaction using at least one specific primer to amplify the recombinant polynucleotides prepared by step (b).

[0040] In the polymerization reaction of step (b), when the partially elongated DNA fragments from specific primers are annealed with the template DNA fragments originated from the other starting double-stranded polynucleotide in the next cycle and the polymerization reaction is progressed, then recombinant polynucleotides containing the sequences originating from the two homologous polynucleotides in a polynucleotide are resulted therefrom. By repeating such PCR cycles, it is possible to obtain various mutant recombinant polynucleotides having randomly reassembled sequences between A and B gene as shown in FIG. 1.

[0041] In addition, the present invention provides a method for constructing a recombinant DNA library, comprising the steps of inserting the recombinant polynucleotide prepared as above into a vector; and transforming an expression cell with said vector containing the recombinant polynucleotide to obtain a plurality of mutant clones.

[0042] It is possible to screen a useful gene from the recombinant DNA library constructed by the inventive method.

[0043] Accordingly, the present invention further provides a method for identifying an improved mutant gene, which comprises screening recombinant polynucleotides having a desired functional property from the recombinant DNA library constructed by the above method.

[0044] The present invention relates to a method for producing a recombinant DNA library by random recombination between two or more genetic materials. According to the present invention, it is possible to synthesize various kinds of recombinant genes by in vitro random recombination and to prepare a novel polypeptide having a desired property by screening a clone having a desired gene from a recombinant DNA library constructed by using the recombinant genes together with a suitable expression vector and a host cell and expressing the polypeptide therefrom.

[0045] As used herein, the term “unidirectional single-stranded DNA or polynucleotide fragments” means that the single-stranded DNA or polynucleotide fragments are not anti-parallel, but parallel to each other and, accordingly, they cannot anneal with each other via complementary hydrogen bonds even if they are mixed together. For instance, when the entire nucleotide sequence of a double-stranded DNA is as follows,

[0046] 5′-AGGTCCAGTTAGCATTCGGAAAGGCCGTTTGAGAGAG-3′ (SEQ ID NO: 17)

[0047] 3′-TCCAGGTCAATCGTAAGCCTTTCCGGCAAACTCTCTC-5′ (SEQ ID NO: 18)

[0048] the single-stranded DNAs derived therefrom such as 3′-TCCAGGTCAATCGTAAG-5′ (SEQ ID NO: 19), 3′-AAACTCTCTC-5′ (SEQ ID NO: 20), 3′-TTTCCGGCAAACTCTCTC-5′ (SEQ ID NO: 21), 3′-CCTTTCCGGCAAACTCTCTC-5′ (SEQ ID NO: 22) and 3′-TCAATCG TAAGCCTTTCCGGCAAACTCTCTC-5′ (SEQ ID NO: 23) are considered to be unidirectional. Such unidirectional single-stranded DNA or polynucleotide fragments, which are employed in the method of the present invention only as templates for polymerase chain reactions, may be prepared to have various lengths depending on the sizes of the polynucleotides to be reassembled.

[0049] The term “recombinant DNA” as used herein means a chimeric DNA of a nucleotide sequence mosaic including nucleotide sequences originating from two-or more-polynucleotides, which are substantially homologous but not identical, in a molecule. The chimeric DNA contains a region of original nucleotide sequence and another region of mutated nucleotide sequence. FIGS. 5 and 6 illustrates such recombinant DNAs synthesized by the random in vitro DNA recombination by the method of the present invention. Unlike the recombinant DNA naturally produced by the gene exchange due to the crossing over between homologous chromosomes in the meiosis during sexual reproduction, the recombinant DNAs of the inventive method is produced to have various nucleotide sequences in a short time by the in vitro random recombination between homologous DNA strands and they can be inserted into a vector and expressed in a host cell transformed by the vector. A recombinant DNA library consisting of clones containing various recombinant DNAs can be constructed and a recombinant DNA having a desired property can be screened therefrom. As discussed above, the combination of in vitro production of random recombinant DNA library between two or more homologous polynucleotides with a screening technique mimicking the natural selection has an advantage in that an improved gene or mutant protein having a desired property can be obtained in a short time.

[0050] As used herein, the term “homologous” means that one single-stranded nucleic acid sequence may hybridize to a complementary single-stranded nucleic acid sequence. The degree of hybridization may depend on a number of factors including the amount of identity between the nucleic acid sequences and the hybridization conditions such as temperature and salt concentration.

[0051] As used herein, the term “mutation” means changes in the sequence of a wild-type nucleic acid sequence or changes in the sequence of a peptide expressed therefrom.

[0052] As used herein, the term “DNA library” means a set of polynucleotides or recombinant DNA fragments each consisting of two or more polynucleotides and produced by random recombination. The DNA library includes: a set of polynucleotides having various nucleotide sequence; a sum of DNAs having various nucleotide sequences or cloned DNAs; or, in a broad sense, a set of clones containing said DNAs. A recombinant DNA encoding a protein having a desired property can be screened from such DNA library and used for protein expression.

[0053] More specifically, the present invention provides a method for producing recombinant polynucleotides having randomly and artificially mutated various nucleotide sequences from naturally existing or artificially prepared two or more homologous polynucleotides by the following steps. FIG. 1 illustrates this in vitro DNA recombination method.

[0054] Step 1: A set of unidirectional single-stranded polynucleotide fragments of random lengths are generated from two or more starting polynucleotides to be reassembled, wherein the starting polynucleotides have regions of similarity with each other (Step 1 of FIG. 1).

[0055] The starting polynucleotides for use in the present invention may have a homology of more than 50% with each other, and it is preferred to employ starting polynucleotides having homologies of more than 80%.

[0056] All of the single-stranded polynucleotide fragments produced from two or more homologous polynucleotides have identical unidirectional properties. Therefore, they are parallel to each other and, accordingly, a complementary annealing between them through complementary hydrogen bonds cannot occur even if they are mixed together.

[0057] The unidirectional single-stranded polynucleotide fragments can be prepared by any one of conventional methods, e.g., a method producing unidirectional single-stranded polynucleotide fragments from RNA by reverse-transcription, a method for producing single-stranded polynucleotide fragments by gradual unidirectional deletion of nucleotides, a method for producing single-stranded polynucleotide fragments from complementary single-stranded polynucleotides. The single-stranded polynucleotide fragments can be prepared from RNA or single-stranded DNA beginning with random primers (Feinberg, A. P. and Vogelstein, B., Anal. Biochem., 132: 6-13 (1983)) by employing reverse transcriptase (Gerard, G. F. et al., Mol. Biotechnol., 8: 61-77 (1997)), bacteriophage T4 DNA polymerase (Nossal, N. G., J. Biol. Chem., 249: 5668-5676 (1974)), bacteriophage T7 DNA polymerase (Tabor, S. and Richardson, C. C., J. Biol. Chem., 264: 6447-6458 (1989)), Klenow enzyme (Klenow, H. and Henningsen, I., Proc. Natl. Acad. Sci. USA, 65: 168 (1970)), etc. At this time, the size of single-stranded polynucleotide can be regulated by controlling the concentration of random primers or adding an appropriate concentration of dideoxynucleotides (2′,3′-dideoxyadenosine 5′-triphosphate, 2′,3′-dideoxyguanosine 5′-triphosphate, 2′,3′-dideoxycytidine 5′-triphosphate, 2′,3′-dideoxythymidine 5′-triphosphate) to the reaction mixture to obtain single-stranded polynucleotide fragments of which length is gradually elongated from the random primers. The single-stranded polynucleotide fragments having gradual unidirectional deletions of nucleotides may be obtained by employing exonucleases capable of successively digesting the nucleotides from the 5′ end of a single-stranded polynucleotide.

[0058] More specifically, the unidirectional single-stranded polynucleotide fragments can be prepared by any one of the following processes:

[0059] A process comprising the steps of (i) conducting a transcription process to produce RNA from at least one starting polynucleotide; and (ii) conducting a reverse transcription process, wherein random primers are used as primers and the RNA transcript of step (i) as a template;

[0060] A process comprising the steps of (i) generating a 3′-overhang on one side of the starting double-stranded polynucleotides by digesting with at least one restriction enzyme; (ii) producing a pool of double-stranded polynucleotides having unidirectional sequential deletion by treating the reaction mixture of step (i) with exonuclease III followed by removing aliquots of-the reaction mixture at a chosen time interval and further blocking the activity of the exonuclease III; (iii) treating the resulting double-stranded polynucleotides having a 5′-overhang with an S1 nuclease and a DNA polymerase to form a blunt end thereof; (iv) generating a new 3′-overhang to the same side which has 3′-overhang in step (i); and (v) treating the polynucleotides of step (iv) with exonuclease III to generate single-stranded polynucleotides;

[0061] A process comprising the steps of (i) generating a 3′-overhang on one side of the starting double-stranded polynucleotides by digesting with at least one restriction enzyme; (ii) treating the polynucleotides of step (i) with exonuclease III to generate single-stranded polynucleotides; and (iii) conducting a polymerization process on the single-stranded polynucleotides of step (ii) using random primers;

[0062] A process comprising the steps of (i) generating a 3′-overhang on one side of the starting double-stranded polynucleotides by digesting with at least one restriction enzyme; (ii) treating the polynucleotides of step (i) with exonuclease III to generate single-stranded polynucleotides; and (iii) producing a pool of single-stranded polynucleotides having unidirectional sequential deletion by treating the single-stranded polynucleotides of step (ii) with a single-strand specific 5′→3′ exonuclease followed by removing aliquots of the reaction mixture at a chosen time interval and further blocking the activity of the exonuclease.

[0063] A process comprising the steps of (i) conducting a polymerase chain reaction on the starting double-stranded polynucleotides using only one kind of oligonucleotide among forward and reverse primers; (ii) isolating the resulting single-stranded polynucleotides from the starting double-stranded polynucleotides; and (iii) conducting a polymerization process on the single-stranded polynucleotides of step (ii) using random primers;

[0064] A process comprising the steps of (i) conducting a polymerase chain reaction on the starting double-stranded polynucleotides using only one kind of oligonucleotide among forward and reverse primers; (ii) isolating the resulting single-stranded polynucleotides from the starting double-stranded polynucleotides; and (iii) treating the single-stranded polynucleotides of step (ii) with a single-strand specific 5′→3′ exonuclease followed by removing aliquots of the reaction mixture at a chosen time interval and further blocking the activity of the exonuclease; and

[0065] A process for preparing the steps of (i) isolating a single-stranded polynucleotide from a viral vector or plasmid vector which has at least one starting polynucleotide insert; and (ii) conducting a polymerization process on the single-stranded polynucleotides of step (i) using random primers.

[0066] Step 2: The second step of the inventive method may comprise the steps of (i) conducting at least one cycle wherein the primers are extended to the end of the unidirectional single-stranded DNA fragments used as templates; (ii) conducting at least one subsequent cycle wherein each of the resulting extended polynucleotides of step (i) is further extended to the end of an unidirectional single-stranded DNA fragment other than the unidirectional single-stranded DNA fragment used in step (i) by means of template switching; and (iii) repeating step (ii) until recombinant polynucleotides of desired length are obtained.

[0067] Specifically, the unidirectional single-stranded polynucleotide fragments of various lengths prepared in Step 1 are mixed together, a specific oligonucleotide having a nucleotide sequence complementary to the single-stranded polynucleotide fragments are added thereto, and a polymerase chain reaction is carried out under a proper stringency. Then, the specific oligonucleotide serves as a primer of polymerase chain reaction and is elongated gradually at one direction (5′→3′) in each turn of reactions, whereby the recombination reaction occurs. The synthesized polynucleotides are separated into single strands by denaturation process and re-annealed. At this time, the synthesized polynucleotide may be annealed with other polynucleotide fragment containing a homologous sequence.

[0068] More specifically, a mixture of double-stranded polynucleotides can be denatured by heat and consequent polymerase chain reaction consists of the following three steps. First, double-stranded template DNA is treated at 90 to 98° C. for 10 sec to 5 min in order to separate into single-strands (denaturation). Thereafter, by lowering the temperature, previously added primers are annealed with a complementary single-stranded template DNA (annealing). This step is carried out at 40 to 72° C. for 10 sec to 2 min. Then, upon regulation of the temperature within a range of 70 to 78° C., four kinds of dNTPs (dATP, dGTP, dCTP, dTTP) in the reaction mixture begin to react and a is DNA complementary to the template DNA is synthesized and elongated. The reaction time depends on the length of DNA being synthesized.

[0069] In case of producing various recombinant DNAs in such a manner from two or more polynucleotides having homologous nucleotide sequences, a polynucleotide may extend from an oligonucleotide primer, which is capable of hybridizing with at least one of the starting polynucleotides, up to the 5′ end of the unidirectional single-stranded DNA fragment used as a template in a cycle of synthesis; and the resulting polynucleotide may further extend to the end of other unidirectional single-stranded polynucleotide originating from other starting polynucleotide by template switching in the next cycle. At this time, a recombination boundary is formed between the oligonucleotides synthesized by employing as templates unidirectional single-stranded polynucleotides originating from different starting polynucleotides.

[0070] In Step 2 for the extension of polynucleotide, the unidirectional single-stranded polynucleotide fragments prepared in Step 1 are employed only as templates for generating the recombinant DNAs and, accordingly, the primers added at the begining are extended gradually to one direction (5′→3′) using them as templates through the repetitive PCR to result in generation of recombinant polynucleotides.

[0071] In Step 2, the DNA recombination is conducted by periodically repeating the steps of denaturation, annealing and extension at the presence of DNA polymerase for the desired period. The degree of recombination depends on the homology between the groups of single-stranded polynucleotides derived from different starting polynucleotides.

[0072] Step 3: By sufficiently repeating the PCR cycles of Step 2 and amplifying the resulting mutant recombinant polynucleotides by a normal PCR method, a recombinant double-stranded DNA library is prepared. The recombinant DNA library thus obtained may consist of various kinds of mutant double-stranded polynucleotides which contain in a molecule the identical and heterogenous regions as compared with corresponding regions of any one of the starting double-stranded polynucleotides. The nucleotide sequence of the recombinant DNA may be determined by a conventional method, e.g., Maxam-Gilbert's method (Maxam, A. M and Gilbert, W., Mol. Biol. (Mosk), 20: 581-638 (1986)), Dideoxy method (Messing, J. et al., Nucleic Acids Res., 24; 309-321(1981)), or a method using DNA fluorescence marker and automated DNA sequence analyzer.

[0073] The present invention further provides a method for constructing a recombinant DNA library for screening a desired gene using the recombinant DNAs obtained by the above method. Specially, it comprises the steps of inserting the mutant recombinant double-stranded DNA obtained in Step 3 into an appropriate expression vector, introducing the resulting expression vector into an expression cell to obtain a library containing a plurality of clones; screening a desired polynucleotide from the clones; and expressing a protein from the polynucleotide by a conventional method. Suitable expression methods include: producing and accumulating a gene product in cells; secreting a gene product from a cell and accumulating them in a medium; secreting a gene product into a periplasm; and the like methods. For screening a desired gene product from a recombinant DNA library, the methods known in the art, e.g. immunochemical method, radiochemical method, a method employing surface expressing system, and gene chip screening method, may be employed alone or in combination. In preparing the recombinant DNA library, any expression vector that operates in a selected host cell may be employed, exemplary vectors including conventional vectors of phage, plasmid, phagemid, viral vector and artificial chromosome known in the art. The method-for constructing the expression vector is well known in the art, e.g., in Sambrook, J. et al., Molecular Cloning: A Laboratory Manual, 2^(nd) ed., (1989) Cold Spring Harbor Laboratory Press, N.Y. A suitable host cell may be transformed with the resulting expression vector. The suitable host cells for expressing the recombinant DNA include a bacterium such as E. coli, Bacillus subtilis and B. brevis, etc.; an Actinomyces such as Streptomyces lividans; a yeast such as Saccharomyces serevisiae; a fungus such as Aspergillus oryzae, A. nidulans and A. niger; an animal cell such as COS-7, CHO, Vero and mouse L cells; an insect cell; and a plant cell.

[0074] The present invention provides a method for preparing various, random, mutant recombinant DNAs in a short period of time. Specifically, a library of mutant recombinant polynucleotides can be obtained by adding oligonucleotide primers to a mixture of unidirectional single-stranded DNA fragments derived from two or more of homologous nucleic acid sequences or polynucleotides; and conducting repetitive PCR to obtain the library of mutant recombinant polynucleotides, wherein random recombinations between the nucleotide sequences of the single-stranded oligonucleotide fragments are occurred.

[0075] The recombinant DNAs prepared by the inventive method may be genes encoding proteins, e.g., enzymes, antibodies, vaccines (antigens), hormones, growth factors, binding proteins and plasma proteins. For instance, the recombinant DNA may encode an enzyme, said enzyme being selected from the group consisting of hydrolase, lyase, transferase, oxidoreductase, ligase and isomerase. A preferred embodiment of the present invention provides a method for constructing a recombinant DNA library by preparing a recombinant gene (recombinant DNA) having a random mutation between Serratia marcescens chitinase gene (SEQ ID NO: 1, designated “m-chi”) and S. liquefaciens chitinase gene (SEQ ID NO: 2, designated “l-chi”) and cloning the recombinant gene. About 10,000 clones were prepared by the inventive method and, among them, 10 clones were randomly selected to determine the nucleotide sequences thereof. Comparison of their nucleotide sequences with those of the two wild-type genes exhibited that one time of recombination is occurred between the two genes in recombinant clones 3, 4 and 10; two times of recombinations, in recombinant clones 1, 2, 7 and 8; three times of recombinations, in recombinant clones 6 and 9; and four times of recombinations, in recombinant clone 5. These results demonstrate that the inventive method is effective in constructing a recombinant DNA library having a random recombination between two or more kinds of polynucleotides.

[0076] The inventive method for constructing a recombinant DNA library has a wide applicability. This in vitro mutagenization method may be used in a laboratory as means for biochemical studies. Since it allows to understand the mechanism of a protein involving in the maintenance and regulation of life in a molecular level, it may be used as means for producing and screening a proten such as an enzyme, antibody, vaccine (antigen), hormone, adsorption protein or plasma protein, thereby inducing the change of substrate specificity, change of reaction specificity, increase of activity, change of antigenicity, change of safety of a protein. Therefore, it is ultimately applied to various industrial fields for the development of a medicine, improvement and enhancement of food quality, improvement of energy conversion rate, breeding and quality improvement in livestock and fishery, development and production of novel chemical product, etc. (Chartrain M. et al., Curr. Opin. In Biotech., 11: 209-214 (2000); Miyazaki K. et al., J. Mol Biol., 297: 1015-1026 (2000); Giver, L. and Arnold, F. H., Curr. Opin. Chem. Biol., 2: 335-338 (1998); Kumamaru, T. et al., Nat. Biotechnol., 16: 663-666 (1998); and Patten, P. A., Curr. Opin. Biotechnol., 8: 724-733 (1997)).

[0077] The present invention is further defined in the following Examples. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these-Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usage and conditions.

Example 1 Generating Unidirectional Single-Stranded Polynucleotide Fragments

[0078] A pool of unidirectional single-stranded polynucleotide fragments having random length was prepared from a pair of double-stranded polynucleotides which have regions of similarity with each other as follows:

[0079] 1-1) Preparation of Unidirectional Single-Stranded DNA Fragments by Reverse Transcription

[0080] In an embodiment of the present invention, genes encoding chitinase of Serratia marcescens and Serratia liquefaciens (hereinafter, referred to as “m-chi” and “l-chi”, respectively) were chosen as starting polynucleotides to be reassembled, the nucleotide sequences of which are described in FIG. 2.

[0081] HindIII/Xba I fragments containing m-chi and l-chi genes, respectively, were cloned into pUC19, resulting in pUC19-m-chi and pUC19-l-chi. These plasmids were treated with Nde I, gap-filled with Klenow and then digested with HindIII. The resulting DNA inserts of about 2-kb were ligated to the HindIII/EcoRV backbone of pBluescript II KS (Stratagene) to give 5-kb recombinant plasmids. The resulting plasmids, pBSK-m-chi and pBSK-l-chi, were then linearized with Spe I.

[0082] 200 ng of the linearized plasmids was added to transcription buffer solution [40 mM Tris-HCl (pH 7.9), 6 mM MgCl₂, 2 mM spermidine, 10 mM NaCl, 10 mM DTT] supplemented with 0.5 mM each rNTP, 40 units of RNasin and 17 units of T3 RNA polymerase up to the total volume of 20 μl and incubated at 37° C. for 1 hour. The RNA transcripts of the m-chi and l-chi genes obtained by the above in vitro transcription were analyzed by electrophoresis on 1% agarose gel. The bands of 5-kb plasmid and RNA transcripts are detected in lanes 2 and 3 of FIG. 3(a). Purified with RNAeasy column (Qiagen), 200 ng of each RNA transcribed from the two chitinase genes was mixed. The RNA mixture was added to the reaction buffer [10 mM Tris-HCl (pH 8.3), 15 mM KCl, 0.6 mM MgCl₂, 0.2 mM DTT] supplemented with 6 μg of random hexamer (Genotech, Inc.), 0.2 mM each dNTP, 40 units of RNasin and 50 units of M-MLV reverse transcriptase to the total volume of 50 μl and reverse transcription was performed at 37° C. for 1 hour. After the reverse transcription, the RNA templates were removed by incubating the reaction mixture with 20 ng of RNase I at 37° C. for 1 hour.

[0083] Since the random hexamer can be hybridized with the template RNA at all the location thereof by chance, nucleotide extension from the random hexamer generates unidirectional single-stranded DNA fragments with random length.

[0084] The products of reverse transcription were electrophorezed on 1% agarose gel (lane 2, FIG. 3(b)) and the single-stranded DNA fragments were cut and purified using a Geneclean kit (Bio 101).

[0085] 1-2) Preparation of Unidirectional Single-Strand DNA Fragments with Serial 5′ Deletions

[0086] This method is based on two useful features of exonuclease III: (i) processive digestion at a very uniform rate and (ii) failure to initiate digestion at DNA ends with 4-base 3′-protrusions (Henikoff, S., Gene 28, 351-359, 1984).

[0087] Plasmid pGEM-T (Promega) having m-chi gene of 30,g was linearized with a pair of restriction enzymes, Sph I and Nco I, wherein Sph I produces 4-base 3′-protrusions resistant to the exonuclease III digestion while Nco I generates 4-base 5′-overhanging ends. As for l-chi gene, the above process was conducted as same. The linearized polynucleotides dissolved in exonuclease III reaction buffer [66 mM Tris-HCl (pH 8.0), 0.66 mM MgCl₂] up to the volume of 60 μl were digested with 2 units of exonuclease III. 2.5 μl of aliquot was then removed at intervals of twenty seconds, and the enzyme reaction was terminated. The resulting aliquot was mixed with 7.5 μl of S1 nuclease mix [S1 nuclease reaction buffer (300 mM potassium acetate, pH 4.6, 2.5 M NaCl, 10 mM ZnSO₄, 50% glycerol) plus 50 units of S1 nuclease] and then placed at room temperature for 15 minutes.

[0088] After the S1 nuclease was inactivated by S1 stop solution [300 mM Tris base, 50 mM EDTA], polymerization was performed at 37° C. for 30 min by adding Klenow and then the products were cleaved with Sac I. The resulting double-stranded DNA fragments having random deletions sequentially were analyzed by electrophoresis on 1% agarose gel. The DNA fragments were extracted from the gel and reacted with 2 units of exonuclease III for 1 hour to produce a set of single-stranded DNA fragments having unidirectional deletions thereon.

[0089] 1-3) Preparation of Unidirectional Single-Strand DNA Fragments Using Single-Stranded DNA as a Template

[0090] Plasmid pGEM-T (Promega) having each of m-chi and l-chi genes of 5 μg was linearized with a pair of restriction enzymes, Sph I and Nco I. The linearized polynucleotides dissolved in exonuclease III reaction buffer [66 mM Tris-HCl (pH 8.0), 0.66 nM MgCl₂] up to the-volume of 60 μl were digested with 2 units of exonuclease III at 37° C. for 30 min.

[0091] The resulting linearized single-stranded polynucleotides were used as templates to generate the single-stranded DNA fragments in a polymerization mix [10 units of Klenow, 6 μg of random hexamers, 0.1 mM each dNTP, 10 mM Tris-HCl (pH 7.5), 5 mM MgCl₂, 7.5 mM DTT] at 37° C.

[0092] The resulting unidirectional single-stranded DNA fragments were analyzed by electrophoresis on 1% agarose gel and subsequently purified using a Geneclean kit (Bio 101).

Example 2 Reassembly of Polynucleotides by Polymerase Chain Reaction Using the Unidirectional Single-Stranded DNA Fragment as a Template

[0093] The unidirectional single-stranded DNA fragments obtained above served as templates for polymerase chain reaction. A reaction mixture contained 20 ng of the single-stranded DNA fragments, 0.2 mM each dNTP, 2 MM MgCl₂, 50 mM KCl, 10 mM Tris-HCl (pH 8.8), 0.1% Triton X-100, 2 units of Vent DNA polymerase (New England BioLabs) and 25 pmole of a primer in a total volume of 50 μl, wherein the primer being an oligonucleotide (SEQ ID NO: 24) having the nucleotide sequence identical to those at the 5′ termini of m-chi and l-chi genes. PCR was carried out on an MJ Research thermal cycler (PTC-100) at 94° C. for 3 min; 94° C. for 30 seconds, 55° C. for 30 seconds, 72° C. for 30 seconds (30 cycles); and 72° C., 5 min. For the amplification of a full-length DNA, secondary PCR was carried out on the above PCR products using 25 pmole of a 3′-specific oligonucleotide (SEQ ID NO: 25) as a primer. PCR was carried out on an MJ Research thermal cycler (PTC-100) at 94° C. for 3 min; 94° C. for 30 seconds, 55° C. for 30 seconds, 72° C. for 30 seconds (30 cycles); and 72° C., 5 min. The resulting PCR products of about 1.7 kb were analyzed by 1% agarose gel electrophoresis (lane 2, FIG. 3(c)).

Example 3 Sequencing and Screening

[0094] The PCR products of example 2 were extracted from the gel by a Geneclean kit (Bio 101), digested with HindIII and Xba I, and ligated to the HindIII/Xba I backbone of pBluescript II KS. The resulting recombinant plasmid was transformed to E. coli JM83 and transformants were selected on LB-agar plates supplemented with 100 μg/ml ampicillin. Plasmid DNA was isolated from the randomly chosen 14 colonies by Qiagen Spin Miniprep kit (Qiagen) and digested with restriction enzymes, Not I, Pst I and Hinc II.

[0095]FIG. 4 shows various sizes of DNA resolved by usual electrophoresis on 1% agarose gel. The band patterns of DNA fragments of l-chi gene cleaved with the same three restriction enzymes are shown in lane 5, those of m-chi gene in lanes 8 and 13. The remaining lanes represent patterns of random recombinant DNA reassembled from m-chi and l-chi genes, the patterns different from those of wild type DNA fragments. These results show that at least 11 clones of the randomly selected 14 clones contain recombinant DNA reassembled from a pair of the wild-type DNA.

[0096] To identify the resulting recombinant DNA, HindIII/Xba I fragment of the 10 plasmids was sequenced using the ABI PRISM Dye terminator Cycle Sequencing Kit (PE Biosystems) and the sequences were compared with those of the wild-type m-chi and l-chi genes, alignments of which were shown in FIG. 5 and further depicted in the schematic diagram of FIG. 6.

[0097] As shown in FIG. 6, recombination between the two wild-type genes took place once as for the recombinant DNA clones 3, 4 and 10; twice as for clones 1, 2, 7 and 8; three times as for clones 6 and 9; and four times as for clone 5. These results suggest that the method of the present invention using unidirectional single-stranded polynucleotides can efficiently generate a random recombinant DNA library from two or more kinds of starting polynucleotides.

[0098] To screening a recombinant polynucleotide encoding a chitinase which has specific activity higher than that of wild-type enzyme, the colonies were transferred by replica-plating method to LB-agar plates containing 100 μg/ml ampicillin and 0.5% swollen chitin, and incubated at 37° C. overnight until clear plaques were developed. About 800 colonies were screened according to the degree of their clearance. FIG. 7 shows the variance of the sizes of clear zones formed by the colonies expressing the recombinant chitinase depending on their chitin decomposing activities different from each other. A chitinase produced by a colony forming a clear zone larger than wild type was designated R-24 chitinase. Plasmid DNA was extracted from the clone by Qiaprep Spin Miniprep method (Qiagen) and the nucleotide sequence of R-24 chininase gene was analyzed. FIG. 8 compares the nucleotide sequence of R-24 chininase gene (SEQ ID NOs: 13) with those of two wild-type genes, i.e., l-chi gene (SEQ ID NO: 1) and m-chi gene (SEQ ID NO: 2). FIG. 9 is a schematic diagram showing the constitution of R-24 chininase gene in comparison with the two wild-type genes. From FIG. 9, it can be seen that R-24 chitinase gene was produced by four times of recmbinations between the two wild-type genes.

[0099] Table 1 shows the comparison of the specific activity of R-24 chitinase with those of the two wild-type chitinases. TABLE 1 Specific activities of the wild-type chitinases and recombinant R-24 chitinase Chitinase Specific activity (U/mg) Serratia marcescens chitinase 150.6 Serratia liquefaciens chitinase 201.3 R-24 chitinase 227.2

[0100] As can be seen from Table 1, specific activity of R-24 chitinase is higher than Serratia marcescens chitinase and Serratia liquefaciens chitinase by factors of 1.5 and 1.1, respectively.

Example 4 Directed Evolution of a Chitosanase for Thermostability

[0101] 4-1) Preparation of Mutant Chitosanases by Error-Prone PCR

[0102] About 0.5-kb DNA fragment obtained by EcoRV/Sal I double digestion of pBR322 was inserted into EcoRV/Sal I digestion site of pBluescript II SK. The resulting vector construct was then cut with Xba I and EcoR I, and ligated to about 1.4-kb chitosanase gene obtained by digesting Bacillus sp. (KCTC 0377BP) with same restriction enzymes, resulting in a recombinant vector construct, pBSK-csn-322, containing chitosanase gene.

[0103] The pBSK-csn-322 was used as a template for error-prone polymerase chain reaction. Each 50 pmole of primers csn-Xba I (SEQ ID NO: 26) and csn-c1(SEQ ID NO: 27) was used for an error-prone PCR reaction which was performed in 100 μl of PCR mix comprising 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 4 mM MgCl₂, 0.2 mM dATP, 0.2 mM dGTP 1 mM dCTP, 1 mM dTTP, 0.15 mM MnCl₂, 10 ng of template DNA and 5 units of Taq polymerase using an MJ Research Thermal cycler (PTC-200). The PCR conditions were as follows: 94° C. for 3 min; 94° C. for 30 seconds, 55° C. for 30 seconds and 72° C. for 30 seconds (30 cycles); and followed by 72° C., 5 min.

[0104] The resulting 1.4-kb DNA fragment was digested with Xba I and EcoR I, then ligated to Xba I/EcoR I backbone of pBSK-csn-322. The resulting recombinant plasmid was transformed to E. coli JM83 and positive transformants were selected by culturing them on LB-agar plates supplemented with 100 μg/ml ampicillin at 37° C. for 18 hours. The colonies formed on the plates were replica-plated onto a fresh plates and incubated at 37° C. for 20 hours. The petri dish containing the colonies was heated on a water bath at 70° C. for 15 minutes, and then 50 mM Na-acetate buffer solution containing 0.1% chitosan and 1% agarose was poured-onto the LB-agar plates. After the plates was placed at 37° C. for 24 hours, colonies still having chitosanase activity to produce clear plaques were selected using 0.2% Congo Red. As a result of aforementioned process, 9 positive clones having improved thermal stability were isolated out of about 12,000 clones. Plasmid DNAs were extracted from the clones by Qiaprep Spin Miniprep method (Qiagen) and the nucleotide sequences of chitosanase genes therein were analyzed. Table 2 shows the amino acid substitution sites of thermostable mutant chitosanases produced by error-prone PCR in comparison with the wild-type chitosanase. TABLE 2 Amino acid substitution sites of thermostable mutant chitosanases produced by error-prone PCR Mutant chitosanase Amino acid substitution sites d10−68 D305G e3−97 E308G e4−12 I389M e15−20 T131I, N368D e18−5 S24P, T277A, N368D e22−23 K172E, S376P e26−27 Q159R e26−98 E107D, Q442R e30−97 S376P, Y451C

[0105] 4-2) Construction of the First Recombinant DNA Library and Screening

[0106] DNA reassembly process according to the present invention was carried out using the 9 mutant chitosanase genes selected in 4-1) above as starting polynucleotides.

[0107] The plasmids extracted from the 9 clones were mixed in each quantity of 500 ng and then the linearized DNA fragments of about 4.9-kb in size were obtained by Xho I digestion. The linearized fragments of 200 ng were transcribed in 20 μl of transcription buffer solution [40 mM Tris-HCl, pH 7.8, 6 mM MgCl₂, 2 mM spermidine, 10 mM NaCl, 10 mM DTT] containing 0.5 mM each rNTPs, 40 units of RNasin and 17 unist of T3 RNA polymerase at 37° C. for 1 hour. The resulting RNA transcripts of the mutant genes for chitosanase were purified in RNAeasy column (Qiagen).

[0108] Reverse Transcription was conducted on 200 ng of the RNA in 50 μl of reaction solution [10 mM Tris-HCl, pH 8.3, 15 mM KCl, 0.6 mM MgCl₂, 0.2 mM DTT] containing 6 μg of random hexamer, 0.2 mM each dNTPs, 40 units of RNasin and 50 units of M-MLV reverse transcriptase at 37° C. for 1 hour. The template RNA was then removed by RNase I at 37° C. for 1 hour. Through the reverse transcription process, unidirectional single-stranded DNAs of random size were synthesized from the random hexamer annealed with the template RNA. The resulting single-stranded DNA was analyzed by 1% agarose gel electrophoresis and extracted from the gel using a Geneclean kit (Bio 101).

[0109] The unidirectional single-stranded DNA fragments obtained above served as templates for polymerase chain reaction. A reaction mixture contained 10 ng of single-stranded DNA fragments, 0.2 mM each dNTP, 2 mM MgCl₂, 50 mM KCl, 10 mM This-HCl (pH 8.8), 0.1% Triton X-100, 2 units of Vent DNA polymerase (New England BioLabs) and 25 pmole of csn-Xba I primer (SEQ ID NO: 26) in a total volume of 50 μl. PCR was carried out on an MJ Research thermal cycler (PTC-100) at 94° C. for 3 min; 94° C. for 30 seconds, 55° C. for 30 seconds, 72° C. for 30 seconds (30 cycles); and 72° C., 5 min. The full-length DNA of about 1.4-kb in size was then amplified by PCR using 25 pmole of csn-c1 primer (SEQ ID NO: 27) under the same conditions as described above. The resulting 1.4-kb DNA was digested with Xba I and EcoR I and then ligated to the Xba I/EcoR I backbone of pBSK-csn-322. The resulting plasmid was transformed to E. coli KM83 and positive transformants were selected on LB-agar plates supplemented with 100 μg/ml ampicillin at 37° C. for 20 hours. Grown colonies were transferred onto fresh plates by replica-plating method and incubated at 37° C. for 20 hours. The plates were heated on water bath at 75° C. for 20 minutes, and then 50 mM Na-acetate solution containing 0.1% chitosan and 1% agarose was added onto the LB-agar plates. After incubated at 37° C. overnight, colonies still having chitosanase activity resulting in clear plaque around them notwithstanding the heat treatment were selected on 0.2% Congo Red.

[0110] Through the aforementioned process, 23 clones having improvement in heat resistance compared to the 8 clones obtained by error-prone PCR were selected out of about 12,000 clones.

[0111] 4-3) Construction of Secondary Recombinant DNA Library and Screening

[0112] Secondary recombinant DNA library was constructed with the 23 mutant chitosanase genes, which had been obtained by the screening of the first recombinant DNA library, through the same process as described in 4-2) above. After heated at 80° C. for 30 min, the resulting colonies of 16,000 or more were screened for mutant chitosanase having more improved thermal stability than the starting materials, 23 mutant chitosanases. Two mutants were selected and polypeptides encoded by them were designated as M-13 and M-20, respectively.

[0113] 4-4) Determination of Amino Acid Substitution Sites and Analysis for Thermal Stability of M-13 and M-20

[0114] From the colonies expressing the mutant chitosanases, M-13 and M-20, plasmid DNAs were extracted and the nucleotide sequences of the chitosanase genes were analyzed. FIG. 10 represents the comparison between the sequences of wild-type chitosanase and the genes encoding M-13 and M-20, respectively. Further, deduced amino acid sequences of the wild-type chitosanase and the thermostable M-13 and M-20 mutants were analyzed and the amino acid substitution sites of the mutant chitosanase different from those of the wild-type chitosanase were presented in Table 3. TABLE 3 Amino acid substitution sites of thermostable mutant chitosanases produced by the inventive method Mutant chitosanase Amino acid substitution sites M-13 chitosanase N60Y, E107D, Q159R, N228T, D305G, E308G, N368D, S376P, F384L, I389M, D435G M-20 chitosanase S24P, E107D, Q159R, N286D, D305G, E308G, N357D, N368D, N371D

[0115] As can be seen from Table 3, when compared with the substitution sites present in the mutants prepared by the error-prone PCR as shown in Table 2, it was exhibited that the substitution sites present in seven mutants, i.e., E107D, Q159R, D305G, E308G, N368D, S376P and 1389M, were accumulated in M-13 chitosanase; and the substitution sites present in six mutants, i.e., S24P, E107D, Q159R, D305G, E308G and N368D, in M-13 chitosanase, by the recombination. This result demonstrates that the method of the present invention is useful for the efficient production of recombinant polynucleotides. On the other hand, it can be seen that in addition to the substitution sites resulted from the recombination between the parent mutants, net 4 and 3 mutation sites were introduced into M-13 and M-20 mutant chitosanases, respectively, during the process of the inventive method.

[0116] In order to determine the thermal stabilities of the mutant chitosanases, the wild-type chitosanase, M-13 mutant and M-20 mutant were treated at 60 C and the remaining activities according to time were determined. FIG. 11 shows the differences in the thermal stabilities of the wild-type chitosanase, M-13 mutant and M-20 mutant. In FIG. 11, half-lives (T_(1/2)) of the enzymes, which means that the activity thereof decreases by 50% as compared to the initial activity, are 5.1 min for the wild-type, 6.9 hours for M-13 mutant and 11.6 hours for M-20 mutant. This result shows that the thermal stabilities at 60° C. of M-13 and M-20 mutants increased by 81 and 136 folds, respectively, than the wild-type chitosanase.

[0117] As can be appreciated from the disclosure and the examples above, the method of the present invention can be used for in vitro recombination of homologous polynucleotides and the directed molecular evolution of proteins for desired properties. It is also contemplated that the method of the present invention has advantages over the conventional methods in that random diversity of the polynucleotides is achieved in a short time.

[0118] While the invention has been described with respect to the above specific embodiments, it should be recognized that various modifications and changes may be made to the invention by those skilled in the art which also fall within the scope of the invention as defined by the appended claims.

1 27 1 1692 DNA Serratia liquefaciens 1 atgcgcaaat ttaataaacc gctgttggcg ttgctgatcg gcagcacgct gtgctctgcg 60 gcgcaggccg ctgcaccggg caaacctacg ttggcctggg gcaataccaa attcgccatt 120 gtcgaagtcg atcaagcggc gacggcttat aataatctgg tgaaagtaaa aagtgccgcc 180 gacgtttctg tttcatggaa tttatggaat ggcgataccg gtaccacggc aaaagtatta 240 ttaaatggca aagaagtttg gagtggtgcc tcaaccggta gttcgggaac cgcaaacttt 300 aaggtgaata aaggcggccg ttatcaaatg caggtggcgt tatgcaacgc cgacggctgt 360 accgccagcg atgcaaccga aattgtggtg gcagataccg acggtagcca tttggcacct 420 ttaaaagaac ctttgttgga aaagaataag ccttataaac aagactccgg caaagtggtt 480 ggctcttatt tcgttgaatg gggcgtttac ggccgtaatt tcaccgtcga taaacttccg 540 gctcagaacc tgacgcacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat cgaaggcagc ttccaggcgt tacagcgttc ctgtcagggg 660 cgtgaagact ttaaggtatc gatccacgat ccgttcgctg cgctgcagaa aggtcagaag 720 ggcgtgaccg cctgggacga cccctacaaa ggcaacttcg gccagttgat ggcgttgaaa 780 caggcgcgcc cggacctgaa aatcctgccg tcgatcggtg gctggacgtt atccgatccg 840 ttcttcttta tgggcgataa ggtgaagcgc gatcgcttcg tcggctcggt gaaggagttc 900 ctgcaaacct ggaagttctt tgatggcgta gatatcgact gggaattccc gggcgggcag 960 ggtgctaacc cgaaactggg cagtacgcag gatggggcaa cctatgtgca gctgatgaaa 1020 gagctgcgcg ccatgctgga tcagctttcg gcggaaacgg gccgtaagta tgaactgacc 1080 tctgcgatca gcgccggcaa ggataaaatc gataaggtgg attacaacac cgcacaaaac 1140 tcgatggatc acattttcct gatgagttac gacttctatg gggcattcga tctgaaaaat 1200 ctgggccacc agactgcgct gaaagcgccg gcctggaaac cggatacggc gtataccacg 1260 gtgaatggcg ttaatgcact gctcacgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 2 1692 DNA Serratia marcescens 2 atgcgcaaat ttaataaacc gctgttggcg ctgttgatcg gcagcacgct gtgttccgcg 60 gcgcaggccg ccgcgccggg caagccgacc atcgcctggg gcaacaccaa gttcgccatc 120 gttgaagttg accaggcggc taccgcttat aataatttgg tgaaggtaaa aaatgccgcc 180 gatgtttccg tctcctggaa tttatggaat ggcgacgcgg gcacgacggc caagatttta 240 ttaaatggta aagaggcgtg gagtggtcct tcaaccggat cttccggtac ggcgaatttt 300 aaagtgaata aaggcggccg ttatcaaatg caggtggcat tgtgcaatgc cgacggctgc 360 accgccagtg acgccaccga aattgtggtg gccgacaccg acggcagcca tttggcgccg 420 ttgaaagagc cgctgctgga aaagaataaa ccgtataaac agaactccgg caaagtggtc 480 ggttcttatt tcgtcgagtg gggcgtttac gggcgcaatt tcaccgtcga caagatcccg 540 gcgcaaaacc tgacccacct gctgtacggc tttatcccga tctgcggcgg caatggcatc 600 aacgacagcc tgaaagagat tgaaggcagc ttccaggcgt tacagcgctc ctgccagggc 660 cgcgaggact tcaaagtctc ggtccacgat ccgttcgccg cgctgcaaaa agcgcagaag 720 ggcgtgaccg cctgggatga cccctacaag ggcaacttcg gccagctgat ggcgctgaag 780 caggcgcatc ctgacctgaa aatcctgccg tcgatcggcg gctggacgct gtccgacccg 840 ttcttcttca tgggcgacaa ggtgaagcgc gatcgcttcg tcggttcggt gaaagagttc 900 ctgcagacct ggaagttctt cgacggcgtg gatatcgact gggagttccc gggcggcaaa 960 ggcgccaacc ctaacctggg cagcccgcaa gacggggaaa cctatgtgtt gctgatgaag 1020 gagctgcggg cgatgctgga tcagctgtcg gcggaaaccg gccgcaagta tgagctgacc 1080 tccgccatca gcgccggtaa ggacaagatc gacaaggtgg cttacaacgt tgcgcagaac 1140 tcgatggatc acatcttcct gatgagctac gacttctatg gcgccttcga tctgaagaac 1200 ctggggcatc agaccgcgct gaatgcgccg gcctggaagc cggacaccgc ttacaccacg 1260 gtgaacggcg tcaatgcgct gctggcgcag ggcgtcaagc cgggcaagat cgtggtcggc 1320 accgccatgt atggccgcgg ctggaccggg gtgaacggct accagaacaa cattccgttc 1380 accggtaccg ccactgggcc ggttaaaggc acctgggaga acggcatcgt ggactaccgc 1440 caaatcgccg gccagttcat gagcggcgag tggcagtata cctacgacgc cacggcggaa 1500 gcgccttacg tgttcaaacc ttccaccggc gatctgatca ccttcgacga tgcccgctcg 1560 gtgcaggcca aaggcaagta cgtgctggat aagcagctgg gcggcctgtt ctcctgggag 1620 atcgacgcgg ataacggcga tattctcaac agcatgaacg ccagcctggg caacagcgcc 1680 ggcgttcaat aa 1692 3 1692 DNA Artificial Sequence Chitinase recombinant DNA 1 3 atgcgcaaat ttaataaacc gctgttggcg ttgctgatcg gcagcacgct gtgctctgcg 60 gcgcaggccg ctgcaccggg caaacctacg ttggcctggg gcaataccaa attcgccatt 120 gtcgaagtcg atcaagcggc gacggcttat aataatctgg tgaaagtaaa aagtgccgcc 180 gacgtttctg tttcatggaa tttatggaat ggcgataccg gtaccacggc aaaagtatta 240 ttaaatggca aagaagtttg gagtggtgcc tcaaccggta gttcgggaac cgcaaacttt 300 aaggtgaata aaggcggccg ttatcaaatg caggtggcgt tatgcaacgc cgacggctgt 360 accgccagcg atgcaaccga aattgtggtg gcagataccg acggtagcca tttggcacct 420 ttaaaagaac ctttgttgga aaagaataag ccttataaac aagactccgg caaagtggtc 480 ggttcttatt tcgtcgagtg gggcgtttac gggcgcaatt tcaccgtcga caagatcccg 540 gctcagaacc tgacgcacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat cgaaggcagc ttccaggcgt tacagcgttc ctgtcagggg 660 cgtgaagact ttaaggtatc gatccacgat ccgttcgctg cgctgcagaa aggtcagaag 720 ggcgtgaccg cctgggacga cccctacaaa ggcaacttcg gccagttgat ggcgttgaaa 780 caggcgcgcc cggacctgaa aatcctgccg tcgatcggtg gctggacgtt atccgatccg 840 ttcttcttta tgggcgataa ggtgaagcgc gatcgcttcg tcggctcggt gaaggagttc 900 ctgcaaacct ggaagttctt tgatggcgta gatatcgact gggaattccc gggcgggcag 960 ggtgctaacc cgaaactggg cagtacgcag gatggggcaa cctatgtgca gctgatgaaa 1020 gagctgcgcg ccatgctgga tcagctttcg gcggaaacgg gccgtaagta tgaactgacc 1080 tctgcgatca gcgccggcaa ggataaaatc gataaggtgg attacaacac cgcacaaaac 1140 tcgatggatc acattttcct gatgagttac gacttctatg gggcattcga tctgaaaaat 1200 ctgggccacc agactgcgct gaaagcgccg gcctggaaac cggatacggc gtataccacg 1260 gtgaatggcg ttaatgcact gctcacgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 4 1692 DNA Artificial Sequence Chitinase recombinant DNA 2 4 atgcgcaaat ttaataaacc gctgttggcg ttgctgatcg gcagcacgct gtgctctgcg 60 gcgcaggccg ctgcaccggg caaacctacg ttggcctggg gcaataccaa attcgccatt 120 gtcgaagtcg atcaagcggc gacggcttat aataatctgg tgaaagtaaa aagtgccgcc 180 gacgtttctg tttcatggaa tttatggaat ggcgataccg gtaccacggc aaaagtatta 240 ttaaatggca aagaagtttg gagtggtgcc tcaaccggta gttcgggaac cgcaaacttt 300 aaggtgaata aaggcggccg ttatcaaatg caggtggcgt tatgcaacgc cgacggctgt 360 accgccagcg atgcaaccga aattgtggtg gcagataccg acggtagcca tttggcacct 420 ttaaaagaac ctttgttgga aaagaataag ccttataaac aagactccgg caaagtggtt 480 ggctcttatt tcgttgaatg gggcgtttac ggccgtaatt tcaccgtcga taaacttccg 540 gctcagaacc tgacgcacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat cgaaggcagc ttccaggcgt tacagcgttc ctgtcagggg 660 cgtgaagact ttaaggtatc gatccacgat ccgttcgctg cgctgcagaa aggtcagaag 720 ggcgtgaccg cctgggacga cccctacaaa ggcaacttcg gccagttgat ggcgttgaaa 780 caggcgcgcc cggacctgaa aatcctgccg tcgatcggtg gctggacgtt atccgatccg 840 ttcttcttta tgggcgataa ggtgaagcgc gatcgcttcg tcggctcggt gaaagagttc 900 ctgcagacct ggaagttctt cgacggcgtg gatatcgact gggagttccc gggcggcaaa 960 ggcgccaacc ctaacctggg cagcccgcaa gacggggaaa cctatgtgtt gctgatgaag 1020 gagctgcggg cgatgctgga tcagctgtcg gcggaaaccg gccgcaagta tgagctgacc 1080 tccgccatca gcgccggtaa ggacaagatc gacaaggtgg cttacaacgt tgcgcagaac 1140 tcgatggatc acatcttcct gatgagctac gacttctatg gcgccttcga tctgaagaac 1200 ctggggcatc agaccgcgct gaatgcgccg gcctggaagc cggacaccgc ttacaccacg 1260 gtgaacggcg tcaatgcgct gctggcgcag ggcgtcaagc cgggcaagat cgtggtcggc 1320 accgccatgt atggccgcgg ctggaccggg gtgaacggct accagaacaa cattccgttc 1380 accggtaccg ccactgggcc ggttaaaggc acctgggaga acggcatcgt ggactaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 5 1692 DNA Artificial Sequence Chitinase recombinant DNA 3 5 atgcgcaaat ttaataaacc gctgttggcg ctgttgatcg gcagcacgct gtgttccgcg 60 gcgcaggccg ccgcgccggg caagccgacc atcgcctggg gcaacaccaa gttcgccatc 120 gttgaagttg accaggcggc taccgcttat aataatttgg tgaaggtaaa aaatgccgcc 180 gatgtttccg tctcctggaa tttatggaat ggcgacgcgg gcacgacggc caagatttta 240 ttaaatggta aagaggcgtg gagtggtcct tcaaccggat cttccggtac ggcgaatttt 300 aaagtgaata aaggcggccg ttatcaaatg caggtggcat tgtgcaatgc cgacggctgc 360 accgccagtg acgccaccga aattgtggtg gccgacaccg acggcagcca tttggcgccg 420 ttgaaagagc cgctgctgga aaagaataaa ccgtataaac agaactccgg caaagtggtc 480 ggttcttatt tcgtcgagtg gggcgtttac gggcgcaatt tcaccgtcga caagatcccg 540 gcgcaaaacc tgacccacct gctgtacggc tttatcccga tctgcggcgg caatggcatc 600 aacgacagcc tgaaagagat tgaaggcagc ttccaggcgt tacagcgctc ctgccagggc 660 cgcgaggact tcaaagtctc ggtccacgat ccgttcgccg cgctgcaaaa agcgcagaag 720 ggcgtgaccg cctgggatga cccctacaag ggcaacttcg gccagctgat ggcgctgaag 780 caggcgcatc ctgacctgaa aatcctgccg tcgatcggcg gctggacgtt atccgatccg 840 ttcttcttta tgggcgataa ggtgaagcgc gatcgcttcg tcggctcggt gaaggagttc 900 ctgcaaacct ggaagttctt tgatggcgta gatatcgact gggaattccc gggcgggcag 960 ggtgctaacc cgaaactggg cagtacgcag gatggggcaa cctatgtgca gctgatgaaa 1020 gagctgcgcg ccatgctgga tcagctttcg gcggaaacgg gccgtaagta tgaactgacc 1080 tctgcgatca gcgccggcaa ggataaaatc gataaggtgg attacaacac cgcacaaaac 1140 tcgatggatc acattttcct gatgagttac gacttctatg gggcattcga tctgaaaaat 1200 ctgggccacc agactgcgct gaaagcgccg gcctggaaac cggatacggc gtataccacg 1260 gtgaatggcg ttaatgcact gctcacgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 6 1692 DNA Artificial Sequence Chitinase recombinant DNA 4 6 atgcgcaaat ttaataaacc gctgttggcg ctgttgatcg gcagcacgct gtgttccgcg 60 gcgcaggccg ccgcgccggg caagccgacc atcgcctggg gcaacaccaa gttcgccatc 120 gttgaagttg accaggcggc taccgcttat aataatttgg tgaaggtaaa aaatgccgcc 180 gatgtttccg tctcctggaa tttatggaat ggcgacgcgg gcacgacggc caagatttta 240 ttaaatggta aagaggcgtg gagtggtcct tcaaccggat cttccggtac ggcgaatttt 300 aaagtgaata aaggcggccg ttatcaaatg caggtggcat tgtgcaatgc cgacggctgc 360 accgccagtg acgccaccga aattgtggtg gccgacaccg acggcagcca tttggcgccg 420 ttgaaagagc cgctgctgga aaagaataaa ccgtataaac agaactccgg caaagtggtc 480 ggttcttatt tcgtcgagtg gggcgtttac gggcgcaatt tcaccgtcga caagatcccg 540 gcgcaaaacc tgacccacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat cgaaggcagc ttccaggcgt tacagcgttc ctgtcagggg 660 cgtgaagact ttaaggtatc gatccacgat ccgttcgctg cgctgcagaa aggtcagaag 720 ggcgtgaccg cctgggacga cccctacaaa ggcaacttcg gccagttgat ggcgttgaaa 780 caggcgcgcc cggacctgaa aatcctgccg tcgatcggtg gctggacgtt atccgatccg 840 ttcttcttta tgggcgataa ggtgaagcgc gatcgcttcg tcggctcggt gaaggagttc 900 ctgcaaacct ggaagttctt tgatggcgta gatatcgact gggaattccc gggcgggcag 960 ggtgctaacc cgaaactggg cagtacgcag gatggggcaa cctatgtgca gctgatgaaa 1020 gagctgcgcg ccatgctgga tcagctttcg gcggaaacgg gccgtaagta tgaactgacc 1080 tctgcgatca gcgccggcaa ggataaaatc gataaggtgg attacaacac cgcacaaaac 1140 tcgatggatc acattttcct gatgagttac gacttctatg gggcattcga tctgaaaaat 1200 ctgggccacc agactgcgct gaaagcgccg gcctggaaac cggatacggc gtataccacg 1260 gtgaatggcg ttaatgcact gctcacgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 7 1692 DNA Artificial Sequence Chitinase recombinant DNA 5 7 atgcgcaaat ttaataaacc gctgttggcg ctgttgatcg gcagcacgct gtgttccgcg 60 gcgcaggccg ccgcgccggg caagccgacc atcgcctggg gcaacaccaa gttcgccatc 120 gttgaagttg accaggcggc taccgcttat aataatttgg tgaaggtaaa aaatgccgcc 180 gatgtttccg tctcctggaa tttatggaat ggcgacgcgg gcacgacggc caagatttta 240 ttaaatggta aagaggcgtg gagtggtcct tcaaccggat cttccggtac ggcgaatttt 300 aaagtgaata aaggcggccg ttatcaaatg caggtggcat tgtgcaatgc cgacggctgc 360 accgccagtg acgccaccga aattgtggtg gccgacaccg acggcagcca tttggcgccg 420 ttgaaagagc cgctgctgga aaagaataaa ccgtataaac agaactccgg caaagtggtc 480 ggttcttatt tcgtcgagtg gggcgtttac ggccgtaatt tcaccgtcga taaacttccg 540 gctcagaacc tgacgcacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat cgaaggcagc ttccaggcgt tacagcgttc ctgtcagggg 660 cgtgaagact ttaaggtatc gatccacgat ccgttcgctg cgctgcagaa aggtcagaag 720 ggcgtgaccg cctgggacga cccctacaaa ggcaacttcg gccagttgat ggcgttgaaa 780 caggcgcgcc cggacctgaa aatcctgccg tcgatcggtg gctggacgtt atccgatccg 840 ttcttcttta tgggcgataa ggtgaagcgc gatcgcttcg tcggctcggt gaaagagttc 900 ctgcagacct ggaagttctt cgacggcgtg gatatcgact gggagttccc gggcggcaaa 960 ggcgccaacc ctaacctggg cagcccgcaa gacggggaaa cctatgtgtt gctgatgaag 1020 gagctgcggg cgatgctgga tcagctgtcg gcggaaaccg gccgcaagta tgagctgacc 1080 tccgccatca gcgccggtaa ggacaagatc gacaaggtgg cttacaacgt tgcgcagaac 1140 tcgatggatc acatcttcct gatgagctac gacttctatg gcgccttcga tctgaagaac 1200 ctggggcatc agaccgcgct gaaagcgccg gcctggaaac cggatacggc gtataccacg 1260 gtgaatggcg ttaatgcact gctcacgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcccgctcg 1560 gtgcaggcca aaggcaagta cgtgctggat aagcagctgg gcggcctgtt ctcctgggag 1620 atcgacgcgg ataacggcga tattctcaac agcatgaacg ccagcctggg caacagcgcc 1680 ggcgttcaat aa 1692 8 1692 DNA Artificial Sequence Chitinase recombinant DNA 6 8 atgcgcaaat ttaataaacc gctgttggcg ctgttgatcg gcagcacgct gtgttccgcg 60 gcgcaggccg ccgcgccggg caagccgacc atcgcctggg gcaacaccaa gttcgccatc 120 gttgaagttg accaggcggc taccgcttat aataatttgg tgaaggtaaa aaatgccgcc 180 gatgtttccg tctcctggaa tttatggaat ggcgacgcgg gcacgacggc caagatttta 240 ttaaatggta aagaggcgtg gagtggtcct tcaaccggat cttccggtac ggcgaatttt 300 aaagtgaata aaggcggccg ttatcaaatg caggtggcat tgtgcaatgc cgacggctgc 360 accgccagtg acgccaccga aattgtggtg gcagataccg acggtagcca tttggcacct 420 ttaaaagaac ctttgttgga aaagaataag ccttataaac aagactccgg caaagtggtt 480 ggctcttatt tcgttgaatg gggcgtttac ggccgtaatt tcaccgtcga taaacttccg 540 gctcagaacc tgacgcacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat tgaaggcagc ttccaggcgt tacagcgttc ctgtcagggg 660 cgtgaagact ttaaggtatc gatccacgat ccgttcgctg cgctgcagaa aggtcagaag 720 ggcgtgaccg cctgggacga cccctacaaa ggcaacttcg gccagttgat ggcgttgaaa 780 caggcgcgcc cggacctgaa aatcctgccg tcgatcggtg gctggacgtt atccgatccg 840 ttcttcttta tgggcgacaa ggtgaagcgc gatcgcttcg tcggttcggt gaaagagttc 900 ctgcagacct ggaagttctt cgacggcgtg gatatcgact gggagttccc gggcggcaaa 960 ggcgccaacc ctaacctggg cagcccgcaa gacggggaaa cctatgtgtt gctgatgaag 1020 gagctgcggg cgatgctgga tcagctgtcg gcggaaaccg gccgcaagta tgagctgacc 1080 tccgccatca gcgccggtaa ggataaaatc gataaggtgg attacaacac cgcacaaaac 1140 tcgatggatc acattttcct gatgagttac gacttctatg gggcattcga tctgaaaaat 1200 ctgggccacc agactgcgct gaaagcgccg gcctggaaac cggatacggc gtataccacg 1260 gtgaatggcg ttaatgcact gctcacgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 9 1692 DNA Artificial Sequence Chitinase recombinant DNA 7 9 atgcgcaaat ttaataaacc gctgttggcg ttgctgatcg gcagcacgct gtgctctgcg 60 gcgcaggccg ctgcaccggg caaacctacg ttggcctggg gcaataccaa attcgccatt 120 gtcgaagtcg atcaagcggc gacggcttat aataatctgg tgaaagtaaa aagtgccgcc 180 gacgtttctg tttcatggaa tttatggaat ggcgataccg gtaccacggc aaaagtatta 240 ttaaatggca aagaagtttg gagtggtgcc tcaaccggta gttcgggaac cgcaaacttt 300 aaggtgaata aaggcggccg ttatcaaatg caggtggcgt tatgcaacgc cgacggctgt 360 accgccagcg atgcaaccga aattgtggtg gcagataccg acggtagcca tttggcacct 420 ttaaaagaac ctttgttgga aaagaataag ccttataaac aagactccgg caaagtggtt 480 ggctcttatt tcgttgaatg gggcgtttac ggccgtaatt tcaccgtcga taaacttccg 540 gctcagaacc tgacgcacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat cgaaggcagc ttccaggcgt tacagcgttc ctgtcagggg 660 cgtgaagact ttaaggtatc gatccacgat ccgttcgccg cgctgcaaaa agcgcagaag 720 ggcgtgaccg cctgggatga cccctacaag ggcaacttcg gccagctgat ggcgctgaag 780 caggcgcatc ctgacctgaa aatcctgccg tcgatcggcg gctggacgct gtccgacccg 840 ttcttcttca tgggcgacaa ggtgaagcgc gatcgcttcg tcggttcggt gaaagagttc 900 ctgcagacct ggaagttctt cgacggcgtg gatatcgact gggagttccc gggcggccaa 960 ggcgccaacc ctaacctggg cagcccgcaa gacggggaaa cctatgtgtt gctgatgaag 1020 gagctgcggg cgatgctgga tcagctgtcg gcggaaaccg gccgcaagta tgagctgacc 1080 tccgcgatca gcgccggcaa ggataaaatc gataaggtgg attacaacac cgcacaaaac 1140 tcgatggatc acattttcct gatgagttac gacttctatg gggcattcga tctgaaaaat 1200 ctgggccacc agactgcgct gaaagcgccg gcctggaaac cggatacggc gtataccacg 1260 gtgaatggcg ttaatgcact gctcgcgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 10 1692 DNA Artificial Sequence Chitinase recombinant DNA 8 10 atgcgcaaat ttaataaacc gctgttggcg ctgttgatcg gcagcacgct gtgttccgcg 60 gcgcaggccg ccgcgccggg caagccgacc atcgcctggg gcaacaccaa gttcgccatc 120 gttgaagttg accaggcggc taccgcttat aataatttgg tgaaggtaaa aaatgccgcc 180 gatgtttccg tctcctggaa tttatggaat ggcgacgcgg gcacgacggc caagatttta 240 ttaaatggta aagaggcgtg gagtggtcct tcaaccggat cttccggtac ggcgaatttt 300 aaagtgaata aaggcggccg ttatcaaatg caggtggcgt tatgcaacgc cgacggctgt 360 accgccagcg atgcaaccga aattgtggtg gccgacaccg acggcagcca tttggcgccg 420 ttgaaagagc cgctgctgga aaagaataaa ccgtataaac agaactccgg caaagtggtc 480 ggttcttatt tcgtcgagtg gggcgtttac gggcgcaatt tcaccgtcga caagatcccg 540 gcgcaaaacc tgacccacct gctgtacggc tttatcccga tctgcggcgg caatggcatc 600 aacgacagcc tgaaagagat tgaaggcagc ttccaggcgt tacagcgctc ctgccagggc 660 cgcgaggact tcaaagtctc ggtccacgat ccgttcgccg cgctgcaaaa agcgcagaag 720 ggcgtgaccg cctgggatga cccctacaag ggcaacttcg gccagctgat ggcgctgaag 780 caggcgcatc ctgacctgaa aatcctgccg tcgatcggcg gctggacgct gtccgacccg 840 ttcttcttaa tgggcgacaa ggtgaagcgc gatcgcttcg tcggttcggt gaaagagttc 900 ctgcagacct ggaagttctt cgacggcgtg gatatcgact gggagttccc gggcggcaaa 960 ggcgccaacc ctaacctggg cagcccgcaa gacggggaaa cctatgtgtt gctgatgaag 1020 gagctgcggg cgatgctgga tcagctgtcg gcggaaaccg gccgcaagta tgagctgacc 1080 tccgccatca gcgccggtaa ggacaagatc gacaaggtgg cttacaacgt tgcgcagaac 1140 tcgatggatc acatcttcct gatgagctac gacttctatg gcgccttcga tctgaagaac 1200 ctggggcatc agaccgcgct gaatgcgccg gcctggaagc cggacaccgc ttacaccacg 1260 gtgaacggcg tcaatgcgct gctggcgcag ggcgtcaagc cgggcaagat cgtggtcggc 1320 accgccatgt atggccgcgg ctggaccggg gtgaacggct accagaacaa cattccgttc 1380 accggtaccg ccactgggcc ggttaaaggc acctgggaga acggcatcgt ggactaccgc 1440 caaatcgccg gccagttcat gagcggcgag tggcagtata cctacgacgc cacggcggaa 1500 gcgccttacg tgttcaaacc ttccaccggc gatctgatca ccttcgacga tgcccgctcg 1560 gtgcaggcca aaggcaagta cgtgctggat aagcagctgg gcggcctgtt ctcctgggag 1620 atcgacgcgg ataacggcga tattctcaac agcatgaacg ccagcctggg caacagcgcc 1680 ggcgttcaat aa 1692 11 1692 DNA Artificial Sequence Chitinase recombinant DNA 9 11 atgcgcaaat ttaataaacc gctgttggcg ctgttgatcg gcagcacgct gtgttccgcg 60 gcgcaggccg ccgcgccggg caagccgacc atcgcctggg gcaacaccaa gttcgccatc 120 gttgaagttg atcaagcggc gacggcttat aataatctgg tgaaagtaaa aagtgccgcc 180 gacgtttctg tttcatggaa tttatggaat ggcgataccg gtaccacggc aaaagtatta 240 ttaaatggca aagaagttta gagtggtgcc tcaaccggta gttcgggaac cgcaaacttt 300 aaggtgaata aaggcggccg ttatcaaatg caggtggcgt tatgcaacgc cgacggctgt 360 accgccagcg atgcaaccga aattgtggtg gcagataccg acggtagcca tttggcacct 420 ttaaaagaac ctttgttgga aaagaataag ccttataaac aagactccgg caaagtggtt 480 ggctcttatt tcgttgaatg gggcgtttac ggccgtaatt tcaccgtcga taaacttccg 540 gctcagaacc tgacgcacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat cgaaggcagc ttccaggcgt tacagcgttc ctgtcagggg 660 cgtgaagact ttaaggtatc gatccacgat ccgttcgctg cgctgccgaa aggtcagaag 720 ggcgtgaccg cctgggacga cccctacaaa ggcaacttcg gccagttgat ggcgttgaaa 780 caggcgcgcc cggacctgaa aatcctgccg tcgatcggtg gctggacgtt atccgatccg 840 ttcttcttta tgggcgataa ggtgaagcgc gatcgcttcg tcggctcggt gaaggagttc 900 ctgcaaacct ggaagttctt tgatggcgta gatatcgact gggaattccc gggcgggcag 960 ggtgctaacc cgaaactggg cagtacgcag gatggggcaa cctatgtgca gctgatgaaa 1020 gagctgcgcg ccatgctgga tcagctttcg gcggaaacgg gccgtaagta tgaactgacc 1080 tctgcgatca gcgccggcaa ggataaaatc gataaggtgg attacaacac cgcacaaaac 1140 tcgatggatc acattttcct gatgagttac gacttctatg gggccttcga tctgaagaac 1200 ctggggcatc agaccgcgct gaatgcgccg gcctggaagc cggacaccgc ttacaccacg 1260 gtgaacggcg tcaatgcgct gctggcgcag ggcgtcaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 12 1692 DNA Artificial Sequence Chitinase recombinant DNA 10 12 atgcgcaaat ttaataaacc gctgttggcg ctgttgatcg gcagcacgct gtgttccgcg 60 gcgcaggccg ccgcgccggg caagccgacc atcgcctggg gcaacaccaa gttcgccatc 120 gttgaagttg accaggcggc taccgcttat aataatttgg tgaaggtaaa aaatgccgcc 180 gatgtttccg tctcctggaa tttatggaat ggcgacgcgg gcacgacggc caagatttta 240 ttaaatggta aagaggcgtg gagtggtcct tcaaccggat cttccggtac ggcgaatttt 300 aaagtgaata aaggcggccg ttatcaaatg caggtggcat tgtgcaatgc cgacggctgc 360 accgccagtg acgccaccga aattgtggtg gccgacaccg acggcagcca tttggcgccg 420 ttgaaagagc cgctgctgga aaagaataaa ccgtataaac agaactccgg caaagtggtc 480 ggttcttatt tcgtcgagtg gggcgtttac gggcgcaatt tcaccgtcga caagatcccg 540 gcgcagaacc tgacgcacct gctgtacggc tttatcccga tctgcggcgg tgatggcatc 600 aacgacagcc tgaaagagat cgaaggcagc ttccaggcgt tacagcgctc ctgtcagggg 660 cgcgaagact tcaaggtatc ggtccacgat ccgttcgccg cgctgcagaa agggcagaag 720 ggcgtgaccg cctgggacga cccctacaag ggcaacttcg gccagctgat ggcgctgaag 780 caggcgcgcc cggacctgaa aatcctgccg tcgatcggtg gctggacgtt atccgatccg 840 ttcttcttta tgggcgataa ggtgaagcgc gatcgcttcg tcggctcggt gaaggagttc 900 ctgcaaacct ggaagttctt tgatggcgta gatatcgact gggaattccc gggcgggcag 960 ggtgctaacc cgaaactggg cagtatgcag gatggggcaa cctatgtgca gctgatgaaa 1020 gagctgcgcg ccatgctgga tcagctttcg gcggaaacgg gccgtaagta tgaactgacc 1080 tctgcgatca gcgccggcaa ggataaaatc gataaggtgg attacaacac cgcacaaaac 1140 tcgatggatc acattttcct gatgagttac gacttctatg gggcattcga tctgaaaaat 1200 ctgggccacc agactgcgct gaaagcgccg gcctggaaac cggatacggc gtataccacg 1260 gtgaatggcg ttaatgcact gctcacgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 13 1692 DNA Artificial Sequence R-24 chitinase gene 13 atgcgcaaat ttaataaacc gctgttggcg ttgctgatcg gcagcacgct gtgctctgcg 60 gcgcaggccg ctgcaccggg caaacctacg ttggcctggg gcaataccaa attcgccatt 120 gtcgaagtcg atcaagcggc gacggcttat aataatctgg tgaaagtaaa aagtgccgcc 180 gacgtttctg tttcatggaa tttatggaat ggcgataccg gtaccacggc aaaagtatta 240 ttaaatggca aagaagtttg gagtggtgcc tcaaccggta gttcgggaac cgcaaacttt 300 aaggtgaata aaggcggccg ttatcaaatg caggtggcgt tatgcaacgc cgacggctgt 360 accgccagcg atgcaaccga aattgtggtg gcagataccg acggtagcca tttggcacct 420 ttaaaagaac ctttgttgga aaagaataag ccttataaac aagactccgg caaagtggtc 480 ggttcttatt tcgtcgagtg gggcgtttac ggccgtaatt tcaccgtcga taaacttccg 540 gctcagaacc tgacgcacct gctgtacggc tttatcccta tctgtggcgg tgacggcatc 600 aacgacagcc tgaaagagat tgaaggcagc ttccaggcgt tacagcgctc ctgccagggc 660 cgcgaggact tcaaagtctc ggtccacgat ccgttcgccg cgctgcaaaa agcgcagaag 720 ggcgtgaccg cctgggatga cccctacaag ggcaacttcg gccagctgat ggcgctgaag 780 caggcgcatc ctgacctgaa aatcctgccg tcgatcggcg gctggacgct gtccgacccg 840 ttcttcttca tgggcgacaa ggtgaagcgc gatcgcttcg tcggttcggt gaaagagttc 900 ctgcagacct ggaagttctt cgacggcgtg gatatcgact gggagttccc gggcggcaaa 960 ggcgccaacc ctaacctggg cagcccgcaa gacggggaaa cctatgtgtt gctgatgaag 1020 gagctgcggg cgatgctgga tcagctgtcg gcggaaaccg gccgcaagta tgagctgacc 1080 tccgccatca gcgccggtaa ggacaagatc gacaaggtgg cttacaacgt tgcgcagaac 1140 tcgatggatc acatcttcct gatgagctac gacttctatg gcgccttcga tctgaagaac 1200 ctggggcatc agaccgcgct gaatgcgccg gcctggaagc cggacaccgc ttacaccacg 1260 gtgaacggcg tcaatgcgct gctggcgcag ggcgtgaagc cgggcaaaat cgtggtgggc 1320 accgccatgt acggtcgcgg ttggaccggg gtgaacggtt accagaacaa cattccgttt 1380 accggcaccg ccactggccc ggtgaaaggc acctgggaaa atggcatcgt ggattaccgc 1440 cagatcgcca atgagtttat gagcggcgaa tggcagtaca gctacgatgc taccgctgaa 1500 gcaccctatg tcttcaaacc ttccactggc gatctgatca ccttcgacga tgcgcgctcg 1560 gtgcaggcga agggcaaata tgtgctggat aagcagctgg gcgggttgtt ctcatgggaa 1620 attgacgccg acaacggcga tattctgaat aacatgaaca gcagcctggg caacagcgtc 1680 ggtacgcctt aa 1692 14 1362 DNA Bacillus sp. 14 atgaatggaa aaagaaaaat tttcacatgt atttctattg taggaatcgg actagctagt 60 ttttctaatt ctagtttcgc agcaagtgta acggacaatt cagtacaaaa ttctattccc 120 gtagttaatc aacaagtagc tgctgcaaag gaaatgaaac catttccgca gcaagttaat 180 tatgcaggtg ttataaaacc gaatcatgtt acacaggaaa gtttaaatgc ttctgtaaga 240 agttactacg ataattggaa aaagaaatat ttgaaaaatg atttatcttc tttacctggt 300 ggttattatg taaaaggaga gattacaggt gatgctgatg ggtttaagcc acttggaact 360 tcagaaggtc aagggtatgg gatgataatt acagtattaa tggctggtta tgattcgaat 420 gctcaaaaaa tctatgacgg tttatttaaa acagcaagaa cttttaaaag ttctcaaaat 480 cctaatttaa tgggatgggt tgtcgcagat agtaaaaaag cacaaggtca ttttgattct 540 gctactgatg gagatttaga tattgcgtat tctcttcttc ttgctcataa gcagtgggga 600 tctaatggaa cagtgaatta tttgaaagaa gcacaagaca tgattacaaa aggtattaaa 660 gctagtaatg ttacaaataa taaccgacta aatttaggcg attgggattc taaaagttca 720 cttgatacga gaccatctga ttggatgatg tcacacctta gagcatttta tgaatttaca 780 ggtgataaaa cttggcttac tgttattaat aatttgtacg atgtttatac gcaatttagt 840 aataagtact ctccaaatac aggacttatt tcagatttcg ttgtaaaaaa cccaccacaa 900 cccgcaccta aagacttctt agaggagtca gaatatacaa atgcatatta ttacaatgct 960 agtcgggtac cattgagaat tgtaatggac tatgcgatgt acggcgagaa aagaagtaaa 1020 gtcatttctg ataaagtttc ttcgtggatt caaaataaaa cgaatggaaa tccttctaaa 1080 attgtggatg gttatcaatt aaatggatct aatattggta gttattcaac tgctgtattt 1140 gtttcaccgt ttattgctgc aagtataaca agtagcaata atcaaaagtg ggtaaatagc 1200 ggttgggatt ggatgaagaa taagagagaa agttatttta gtgatagtta taatttatta 1260 actatgttat tcattacagg aaattggtgg aaacctgtac ctgatgatac aaaaatacaa 1320 aatcaaataa atgatgcaat ttatgaagga tacgataatt aa 1362 15 1362 DNA Artificial Sequence M-13 mutant chitosanase gene 15 atgaatggaa aaagaaaaat tttcacatgt atttctattg taggaatcgg actagctagc 60 ttttctaatt ctagtttcgc agcaagtgta acggacaatt cagtacaaaa ttctattccc 120 gtagttaatc aacaagtagc tgctgcaaag gaaatgaaac catttccgca gcaagtttat 180 tatgcaggtg ttataaaacc gaatcatgtt acacaggaaa gtttaaatgc ttctgtaaga 240 agttactacg ataattggaa aaagaaatat ttgaaaaatg atttatcttc tttacctggt 300 ggttattatg taaaaggaga tattacaggt gatgctgatg ggtttaagcc acttggaact 360 tcagaaggtc aagggtatgg gatgataatt acagtattaa tggctggtta tgattcgaat 420 gctcaaaaga tctatgacgg tttatttaaa acagcaagaa cttttaaaag ttctcgaaat 480 cctaatttaa tgggatgggt tgtcgcagat agtaaaaaag cacaaggtca ttttgattct 540 gctactgatg gagatttaga tattgcgtat tctcttcttc ttgctcataa gcagtgggga 600 tctaatggaa cagtgaatta tttgaaagaa gcacaagaca tgattacaaa aggtattaaa 660 gctagtaatg ttaccaataa tacccgacta aatttaggcg attgggattc taaaagttca 720 cttgatacga gaccatctga ttggatgatg tcacacctta gagcatttta tgaatttaca 780 ggtgataaaa cttggcttac tgttattaat aatttgtacg atgtttatac gcagtttagt 840 aataagtact ctccaaatac aggacttatt tcagatttcg ttgtaaaaaa cccaccacaa 900 cccgcaccta aaggcttctt aggggagtca gaatatacaa atgcatatta ttacaatgct 960 agtcgggtac cattgagaat tgtaatggac tatgcgatgt acggcgagaa aagaagtaaa 1020 gtcatttctg ataaggtttc ttcgtggatt caaaataaaa cgaatggaaa tccttctaaa 1080 attgtggatg gttatcaatt agatggatct aatattggta gttatccaac tgctgtattt 1140 gtttcaccgc ttattgctgc aagtacaaca agtagcaata atcaaaagtg ggtaaatagc 1200 ggttgggatt ggatgaagaa taagagagaa agttatttta gtgatagtta taatttatta 1260 actatgttat tcattacagg gaattggtgg aaacccgtac ctggtgatac aaaaatacaa 1320 aatcaaataa atgatgctat ttatgaagga tacgataatt aa 1362 16 1362 DNA Artificial Sequence M-20 mutant chitosanase gene 16 atgaatggaa aaagaaaaat tttcacgtgt atttctattg taggaatcgg actagctagt 60 ttttctaatc ctagtttcgc agcaagtgta acggacaatt cagtacaaaa ttctattccc 120 gtagttaatc aacaagtagc tgctgcaaag gaaatgaaac catttccgca gcaagttaat 180 tatgcaggtg ttataaaacc gaatcatgtt acacaggaaa gtttaaatgc ttctgtaaga 240 agttactacg ataattggaa aaagaaatat ttgaaaaatg atttatcttc tttacctggt 300 ggttattatg taaaaggaga tattacaggt gatgctgatg ggtttaagcc acttggaact 360 tcagaaggtc aagggtatgg gatgataatt acagtattaa tggctggtta tgattcgaat 420 gctcaaaaga tctatgacgg tttatttaaa acagcaagaa cttttaaaag ttctcgaaat 480 cctaatttaa tgggatgggt tgtcgcagat agtaaaaaag cacaaggtca ttttgattct 540 gctactgatg gagatttaga tattgcgtat tctcttcttc ttgctcataa gcagtgggga 600 tctaatggaa cagtgaatta tttgaaagaa gcacaagaca tgattacaaa aggtattaaa 660 gctagtaatg ttacaaataa taaccgacta aatttaggcg attgggattc taaaagttca 720 cttgatacga gaccatctga ttggatgatg tcacacctta gagcatttta tgagtttaca 780 ggtgataaaa cttggcttac tgttattaat aatttgtacg atgtttatac gcaatttagt 840 aataagtact ctccagatac aggacttatt tcagatttcg ttgtaaaaaa cccaccacaa 900 cccgcaccta aaggcttctt aggggagtca gaatatacaa atgcatatta ttacaatgct 960 agtcgggtac cattgagaat tgtaatggac tatgcgatgt acggcgagaa aagaagtaaa 1020 gtcatttctg ataaggtttc ttcgtggatt caaaataaaa cgaatggaga tccttctaaa 1080 attgtggatg gttatcaatt agatggatct gatattggta gttattcaac tgctgtattt 1140 gtttcaccgt ttattgctgc aagtataaca agtagcaata atcaaaagtg ggtaaatagc 1200 ggttgggatt ggatgaagaa taagagagaa agttatttta gcgatagtta taatttgtta 1260 actatgttat tcattacggg aaattggtgg aaacctgtac ctgatgatac aaaaatacaa 1320 aatcaaataa atgatgcaat ttatgaagga tacgataatt aa 1362 17 37 DNA Artificial Sequence Arbitrary polynucleotide 17 aggtccagtt agcattcgga aaggccgttt gagagag 37 18 37 DNA Artificial Sequence Arbitrary polynucleotide 18 ctctctcaaa cggcctttcc gaatgctaac tggacct 37 19 17 DNA Artificial Sequence unidirectional DNA fragment 19 gaatgctaac tggacct 17 20 10 DNA Artificial Sequence Unidirectional DNA fragment 20 ctctctcaaa 10 21 18 DNA Artificial Sequence Unidirectional DNA fragment 21 ctctctcaaa cggccttt 18 22 20 DNA Artificial Sequence Unidirectional DNA fragment 22 ctctctcaaa cggcctttcc 20 23 31 DNA Artificial Sequence Unidirectional DNA fragment 23 ctctctcaaa cggcctttcc gaatgctaac t 31 24 31 DNA Artificial Sequence Oligonucleotide primer 24 cccaagcttc ctctcggaat aaaggaatca g 31 25 22 DNA Artificial Sequence Oligonucleotide primer 25 ttcaccgaac cgacgaagcg at 22 26 25 DNA Artificial Sequence Primer csn-XbaI 26 gctctagaca ttttatgtag taagc 25 27 23 DNA Artificial Sequence Primer csn-c1 27 ccggaattcg tatgctaatt ccc 23 

What is claimed is:
 1. A method for producing recombinant polynucleotides comprising the steps of: (a) generating a pool of unidirectional single-stranded polynucleotide fragments randomized in length from at least one starting polynucleotide to be reassembled, which have regions of similarity with each other; (b) conducting a polymerization process comprising multi-cyclic extension reactions, wherein the unidirectional single-stranded polynucleotide fragments prepared by step (a) serve as templates sequentially and specific oligonucleotides are added to the reaction mixture as primers, the primers being extended by means of template switching to produce at least one recombinant polynucleotide, and the resulting recombinant polynucleotides being different from the starting polynucleotides in nucleotide sequence; and (c) conducting a polymerase chain reaction using at least one specific primer to amplify the recombinant polynucleotides prepared by step (b).
 2. The method of claim 1, wherein step (a) comprises: (i) conducting a transcription process to produce RNA from at least one starting polynucleotide; and (ii) conducting a reverse transcription process, wherein random primers are used as primers and the RNA transcript of step (i) as a template.
 3. The method of claim 1, wherein step (a) comprises: (i) generating a 3′-overhang on one side of the starting double-stranded polynucleotide by digesting with at least one restriction enzyme; (ii) producing a pool of double-stranded polynucleotides having unidirectional sequential deletion by treating the reaction mixture of step (i) with exonuclease III followed by removing aliquots of the reaction mixture at a chosen time interval and further blocking the activity of the exonuclease III; (iii) treating the resulting double-stranded polynucleotides having a 5′-overhang with an S1 nuclease and a DNA polymerase to form a blunt end thereof; (iv) generating a new 3′-overhang to the same side which has 3′-overhang in step (i); and (v) treating the polynucleotides of step (iv) with exonuclease III to generate single-stranded polynucleotide fragments.
 4. The method of claim 1, wherein step (a) comprises: (i) generating a 3′-overhang on one side of the starting double-stranded polynucleotides by digesting with at least one restriction enzyme; (ii) treating the polynucleotides of step (i) with exonuclease III to generate single-stranded polynucleotides; and (iii) conducting a polymerization process on the single-stranded polynucleotides of step (ii) using random primers.
 5. The method of claim 1, wherein step (a) comprises: (i) generating a 3′-overhang on one side of the starting double-stranded polynucleotides by digesting with at least one restriction enzyme; (ii) treating the polynucleotides of step (i) with exonuclease III to generate single-stranded polynucleotides; and (iii) producing a pool of single-stranded polynucleotides having unidirectional sequential deletion by treating the single-stranded polynucleotides of step (ii) with a single-strand specific 5′→3′ exonuclease followed by removing aliquots of the reaction mixture at a chosen time interval and further blocking the activity of the exonuclease.
 6. The method of claim 1, wherein step (a) comprises: (i) conducting a polymerase chain reaction on the starting double-stranded polynucleotides using only one kind of oligonucleotide among forward and reverse primers; (ii) isolating the resulting single-stranded polynucleotides from the starting double-stranded polynucleotides; and (iii) conducting a polymerization process on the single-stranded polynucleotides of step (ii) using random primers.
 7. The method of claim 1, wherein step (a) comprises: (i) conducting a polymerase chain reaction on the starting double-stranded polynucleotides using only one kind of oligonucleotide among forward and reverse primers; (ii) isolating the resulting single-stranded polynucleotides from the starting double-stranded polynucleotides; and (iii) producing a pool of single-stranded polynucleotides having unidirectional sequential deletion by treating the single-stranded polynucleotides of step (ii) with a single-strand specific 5′→3′ exonuclease followed by removing aliquots of the reaction mixture at a chosen time interval and further blocking the activity of the exonuclease.
 8. The method of claim 1, wherein step (a) comprises: (i) isolating a single-stranded polynucleotide from a viral vector or plasmid vector which has at least one starting polynucleotide insert; and (ii) conducting a polymerization process on the single-stranded polynucleotides of step (i) using random primers.
 9. The method of claim 1, wherein step (b) comprises the steps of: (i) conducting at least one cycle wherein the primers are extended to the end of the unidirectional single-stranded DNA fragments used as templates; (ii) conducting at least one subsequent cycle wherein each of the resulting extended polynucleotides of step (i) is further extended to the end of an unidirectional single-stranded DNA fragment other than the unidirectional single-stranded DNA fragment used in step (i) by means of template switching; and (iii) repeating step (ii) until recombinant polynucleotides of desired length are obtained.
 10. The method of claim 1, wherein the specific oligonucleotides of step (b) have specific nucleotide sequences which is capable of hybridizing with at least one starting polynucleotide.
 11. The method of claim 1, wherein the starting polynucleotide is a gene encoding any one of proteins selected from the group consisting of enzymes, antibodies, antigens, binding proteins, hormones, growth factors and plasma proteins, or a part thereof.
 12. The method of claim 11, wherein the enzyme is selected from the group consisting of hydrolase, lyase, transferase, oxidoreductase, ligase and isomerase.
 13. The method of claim 1, wherein the starting polynucleotide is a wild type DNA or a mutant type DNA obtained therefrom.
 14. A method for constructing a recombinant DNA library, comprising the steps of inserting the recombinant polynucleotide prepared by the method of any one of claims 1 to 10 into a vector; and transforming an expression cell with said vector containing the recombinant polynucleotide to obtain a plurality of mutant clones.
 15. The method of claim 14, wherein the vector is selected from the group consisting of a phage, a plasmid, a phagemid, a viral vector and an artificial chromosome.
 16. The method of claim 14, wherein the expression cell is selected from the group consisting of bacteria, fungi, plant cells, animal cells and insect cells.
 17. A method for evolving a polynucleotide toward a desired property which comprises screening recombinant polynucleotides having a desired functional properties from the recombinant DNA library constructed by the method of claim
 14. 